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Abstract
It is known that functional binding sites in the carboxyl-terminus of the hepatocyte 
growth factor (HGF) receptor, c-Met, are required to bind growth factor receptor 
bound protein 2 (Grb2) and transduce the motility and proliferation response to HGF. 
Downstream targets coupled to the Src homology 3 (SH3) domains of Grb2 following 
HGF stimulation are only partly known. A recent finding that approximately 50% of 
the endogenous Grb2 is localised within the detergent-insoluble (cytoskeletal) fraction 
of A431 epidermoid carcinoma cells, implied that Grb2 may link receptor tyrosine 
kinase signals to the cytoskeleton. Therefore Grb2 may be involved in cytoskeletal 
rearrangement during cell motility and invasion.
The significance of Grb2 SH3 domains in driving the cellular phenotype in response 
to HGF was investigated in cell lines expressing the HGF receptor and transfected 
with wild-type and dominant-negative constructs lacking the Grb2 SH3 domains. 
High apoptotic rates of cell transfections have implied that the SH3 domains of Grb2 
are able to sequester phosphoinositide kinases (PI3-Kinase), which is also responsible 
for cell motility downstream of Met, presumably through formation of a protein 
multicomplex, and therefore inactivate or partly inhibit the protein kinase B 
(PKB)/Akt sur/ival pathway.
Recent evidence suggests Grb2 involvment in survival pathways by formation of 
protein multicomplexes. Therefore the involvment of Grb2 in a survival pathway 
through sequestering of PI3-Kinase or Cbl-PI3-Kinase from a Src/Cbl/PI3-Kinase 
complex able to activate PKB/Akt is hypothesized and discussed.
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C h a p t e r  I
1. INTRODUCTION
The ability of living tissue to respond to the environment is critically dependent on the 
ability to translate biochemical interactions, into intracellular signalling events. The 
movement of signals can be as simple as one event, or complex involving many 
interactions leading to many cellular events. The biochemical change which is 
subsequently generated either directly or indirectly, often results in an alteration of the 
nature, activity, or location of one or more proteins inside the responding cell. These 
biochemical changes include phosphorylation by tyrosine kinases and/or 
serine/threonine kinases. Protein phosphorylation modifies the enzyme activities and 
conformation of proteins. The outcome is an alteration in cellular activity and changes 
in the programme of genes expressed within the responding cells. Understanding the 
dynamics of these signal transduction events in normal and disease states is a critical 
focus toward reduction of human morbidity and mortality.
1.1 Protein kinases & Protein phosphatases
Protein kinases are the enzymes that catalyze the phosphorylation of proteins. They 
catalyze reactions of the following type:
ATP + Protein Phosphoprotein + ADP
Protein kinases form a large family of enzymes and play a key role in the control of a 
diverse variety of cellular processes, including the regulation of metabolic pathways, 
cell differentiation and cell proliferation (Hunter, 1995 for review). All known 
eukaryotic protein kinases contain a highly conserved catalytic domain of about 250- 
300 amino acids. Outside the catalytic domain, protein kinases exhibit considerable 
variability and may contain additional subunits, regulatory domains, or both. 
Substantial evidence has linked both tyrosine and serine/threonine phosphorylation to 
increased cellular growth, proliferation and differentiation (Hunter, 1995 for review). 
In these cases removal of the incorporated phosphates is often an event to turn off the 
proliferative signal. A timely and functionally coordinated shift in the activity of 
kinases and phosphatases is required to regulate many cellular processes (Perkins et 
al., 1992; Noguchi et al., 1994).
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1.2 Phosphoinositide kinases
Phosphoinositide kinases (PI3-Kinases) are a group of signal transduction enzymes 
that add phosphate groups to lipids in cell membranes. These lipids initiate other, 
protein-mediated signal transduction cascades that ultimately alter cell behaviour. So 
far at least eight family members of PI3-Kinses have been discovered (Figure 1.1).
Mammalian PI3Ks
d a s s structural fea tu res of catalytic subunits
subun its
catalytic / \ adaptor regulation
p110cr,p,»
P110y
p85a
p85p
P65t
p101
ty rosine  
k inases 
& Ras
heterotrim eric 
G proteins 
& Ras
PI3K-C20, k  6
Tyr k inases? 
heterotrim eric 
G proteins? 
(not Ras)
III Vps34p
analogues p150 constitutive?
O adaptor binding ^  Ras-blnding CZ> C2 PIK kinase core domain
Figure 1.1 Mammalian PI3-Kinases and their features. 
(Adapted from Vanhaesebroeck et a!., 1997)
P13-Kinases catalyze the production of phospholipids which act as second messengers 
without the need for hydrolysis. PI3-Kinases catalyze phosphorylation of PI to P13- 
Phosphate, PI 4-Phosphate to PI 3, 4-bisphosphate, and PI 4,5 bisphosphate to (PIP2) 
to PI 3,4,5-Triphosphate (PIP3). Class lA PI3-Kinases consists of the subunits, p85 or 
p55 and pi 10. Analysis of these proteins showed that the catalytic activity resides in 
the 110 kDa subunit, while the primary structure of the p85a subunit suggested a 
regulatory role. p85 consists of several domains, including two SH2 domains, one 
SH3 and a Ber region. The role of the SH2 domains is to interact with specific 
activated receptors or other tyrosine-phosphorylated proteins and thus to relocate the 
associated catalytic subunit. The SH3 domain is conserved in many signalling 
proteins as well as molecules interacting with the cytoskeleton. This domain also 
mediates protein-protein interactions through the specific recognition of certain
17
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proline-rich sequences. The Ber region; shows limited similarity with part of the 
break point cluster region (her) gene, and is flanked by the two proline-rich motifs. 
Like protein kinases, PI3-Kinases play an important role in mitogenic signalling and 
cell survival, cytoskeletal remodelling, metabolic control, and vesicular trafficking 
(Figure 1.2).
Ptdlns-3-P 1 [P td in » -3 .5 -^  |ptdlm s-3,4-P^ | Ptdlr»-3,4,S-P^ |
I \  I
PH domain
PfK 8W GSK3 p70»«
prolir«ration vttMdc biMkkng
traffklnnfi
Figure 1.2 Signaling through PI3-Kinase lipid products and their targets. 
The lipid products o f  P13-Kinase are indicated at the top o f  the figure, and 
the cellular processes affected by these lipids are indicated at the bottom. 
The black ovals indicate the direct targets o f  each lipid, and the small 
boxes indicate the protein domains that directly bind to them. (Adaptedfrom 
Rameh and Cantley 1999)
P1P3 has been shown to be indispensable for mitogenesis for some cell types (Fantl et 
al., 1992). PI3-Kinase, although inactive in quiescent cells (Wymann 1998), is 
rapidly activated upon stimulation of growth factors, and forms complexes with 
tyrosine phosphorylated sites on activated receptors with tyrosine kinase activity, or 
with tyrosine phosphorylated docking proteins insulin receptor substrate 1 (IRSl), 
(Schlessinger 2000) growth factor receptor bound protein-2 (Grb2) (Wang et al., 
1995) and Grb2 associate binding protein 1 (Gabl) (Schlessinger 2000). PDGF- 
induced activation of PI3-Kinase has been reported to play a crucial role in the 
activation of the kinases PDKl and PKB/AKT, which play an important role in cell 
survival and stimulation of protein synthesis.
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1.3 SH2 and SH3 Domains
SH2 domains
The SH2 domain was first identified in the regulatory regions of several non-receptor 
tyrosine kinases (Sadowski et al., 1986) and has 100 residues homologous to Src. It 
consists of three central anti-parallel p strands forming a p-sheet, extended by a 
highly twisted smaller P-sheet, flanked by two a-helices (Figure 1.3).
Figure 1.3. Structure of the SH2 
domain. Ribbon diagram o f  the 
SH2-C domain o f  
phospholipase-C bound to a 
specific phosphotyrosine- 
containing peptide, anti-parallel 
P-sheets, (green) a-helices 
(blue). The peptide (gold) is 
derived from the cytoplasmic 
domain o f  the PDGF receptor 
(DNDpYlPLPDPK). (Adapted 
from Pascal et al., 1994)
SH2 domains have also been found in unrelated signalling molecules such as PLC-y, 
Ras-Gap and the regulatory p85 subunit of P13-Kinase (Anderson et al., 1990). SH2 
domains bind with high affinity to phosphotyrosine (p-Y)-containing ligands. The 
phosphotyrosine binding is mediated through a mostly polar pocket that contains the 
conserved GTFLLR motif found in most SH2 domains. The p-sheet structure interacts 
with the first two amino acids +1, +2, while the +3 residue is recognized specifically 
by a second more hydrophobic pocket. Thus binding se lec tiv ity  is determ ined  largely  by 
the three am ino acid s fo llo w in g  the phosp hotyrosine and sp ec ific  resid ues in the interacting  
SH2 dom ain . Typically, the Grb2 SH2 domain binds pTyr motifs in a specific pocket 
that contains a strictly conserved arginine residue +2 Asn (Lee et al., 1994, Ward et 
al., 1996, McNemar et al., 1997). The structure of the Grb2 SH2 domain with peptides
19
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containing the pYVNV sequence bound has been solved by both crystallographic 
(Rahuel et al., 1996) and NMR (Ogura et al., 1999) techniques. In contrast to all other 
SH2 domain/peptide complexes solved to date, the peptide does not bind in an 
extended conformation but instead forms a turn. Asn (pY +2) forms several hydrogen 
bonds with the backbone of both the protein and the peptide itself, as well as an 
extensive van der Waals interaction with the tryptophan in position EFl. These 
extensive interactions explain the essential nature of this residue in binding (Kimber 
et al., 2000). In addition to the pY binding role, it has been proposed that certain SH2 
domains may have the ability to bind to phosphoinositides. PtdIns(3,4,5)P3 binds 
directly and selectively to the SH2 domains of p85a and c-Src and can thereby inhibit 
interactions with established pY-containing protein ligands such as phosphorylated 
receptors (Surdo et al., 1999, Rameh et al., 1995). Although a number of interactions 
are possible, SH2 domains frequently bind activated receptor tyrosine kinases 
(Schlessinger, 2000, and Hunter, 2000 for reviews).
Initial evidence of direct interaction between SH2 domains and receptors was shown 
by the fact that v-Crk oncoprotein consisting almost entirely of SH2 and SH3 domains 
could activate an endogenous tyrosine kinase and associate with several 
phosphotyrosines in v-Crk transformed cells (Mayer et al., 1990 and Matsuda et al.,
1990). The Crk SH2 domain was both necessary and sufficient for binding, whereas 
mutant v-Crk proteins with alterations in SH2 were defective in both transforming 
activity and complex formation (Mayer et al., 1990).
SH3 Domains
These small interaction modules were first identified in signaling proteins as a region 
of the homology between PLC-y and v-Crk (Mayer et al., 1988). There are about 60 
residues homologous to Src. Structurally, the SH3 domain folds as a compact p-barrel 
of five to six anti-parallel p-strands. The hydrophobic p-strands are connected by 
hydrophilic loops to form two orthogonal P-sheets, bringing the amino and the 
carboxyl termini of the domain close to each other (Figure 1.4).
20
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Figure 1.4.Structure of the SH3 domain 
The figure shows a Sem5 C-terminal SH3 
domain complexed to the mSos-derived 
sequence PPPVPPRRR (Gold). The basic 
fo ld  o f SH3 domains contains five anti­
parallel p-strands packed to form two 
perpendicular p-sheets (green). The 
ligand-binding site consists o f  a 
hydrophobic patch that contains a cluster 
o f conserved aromatic residues and is 
surrounded by two charged and variable 
/0 0 / 75.(Adapted from www.mshri.on.ca/ pawson)
The ligands of most SH3 domains are peptides containing proline-rich segments of a 
consensus sequence PXXP (where X is any amino acid residue, and P is proline 
appendix 1). This peptide forms a left-handed polyproline (PPIl) helix that lies along 
the binding site of the SH3 domain with its prolines interacting with the hydrophobic 
face of the SH3 domain (Pawson 1995, Morton et al., 1994). From structural studies 
and work using peptide libraries, it is known that the binding site consists of three 
turns of a left-handed proline-2 helix, and that SH3 domains can bind ligands in either 
an N-C or a C-N terminal orientation (Mayer et al., 1995). This is because the proline- 
rich helix lacks peptidic hydrogens to provide polarity, so that either of the two ligand 
orientations can bind. However it is clear that not all SH3 domains recognize the 
PXXP motifs in vivo, and not all of them have been shown to function as specific 
protein binding domains without the help of other domains or other amino acid side- 
chain contacts. The analysis of the SH3 domain is further complicated by the fact that 
some isolated SH3 domains bind to very large number of proteins in vitro, suggesting 
that many of these binding events are artificial. It seems likely that in many cases SH3 
domains bind constitutively, functioning as intracellular adhesives and not as a switch 
(Mayer and Baltimore 1993, Musacchio et al., 1992). Although this is true for the 
SH3 domains of Grb2 which binds to Sos. (Cussac et al., 1994) there are examples
21
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such as where phosphorylation of a protein can allosterically regulate the
availability of its SH3 domains and/or proline-rich target motifs (Finan et al., 1994)
1.4 Other Domains
PH domains & PTB domains
The pleckstrin homology (PH) domain was initially identified as a region of sequence 
homology, of approximately 120 amino acids, that is duplicated in pleckstrin (Mayer 
et al., 1993, Haslam et al., 1993). It was subsequently found that this domain is 
present in a large variety of proteins involved in cellular signalling or cytoskeletal 
functions such as Akt, and in guanine nucleotide releasing factors such as Cdc25, Sos, 
and also in the GTPase dynamin (Gibson et al., 1994). Proteins that contain PH 
domains play a role in cellular signaling or cytoskeletal organization and associate 
with membranes by binding to lipid molecules (for reviews see Bottomley et al., 
1998, Lemmon et al., 1996, Fruman et al., 1999).
The phosphotyrosine-binding (PTB) domain was first identified as a region 
responsible for phosphotyrosine-binding in the signalling adaptor protein She (Van 
der Gerr and Pawson 1995). The domain has also been found in the signaling adaptor 
IRS-1 (Eck et al., 1996). The PTB domains have exactly the same topology as PH 
domains (Eck et al., 1996). PTB domains bind to phosphotyrosines in particular 
activated receptor tyrosine kinases, so, like PH domains, PTB domains serve to bring 
She and IRS-1 close to the membrane surface. It is noteworthy that the guanine 
nucleotide releasing factor Sos possesses its own PH domain, elimination of which 
compromises the ability of Sos to activate Ras (McCollam et al., 1995).
1.5 The Ras/ MAP-Kinase Signaling pathway
Mitogen Activated Protein Kinases 1 and 2 (MAPKl, and 2) (also known as ERKl, 
and 2) are extracellular signal-regulated protein kinases. ERKl and ERK2 are 
activated by diverse extracellular stimuli including receptor tyrosine kinases and 
induce proliferation, enhance differentiation and have an impact on many processes in 
the cytoplasm, the nucleus, the cytoskeleton, and the membrane (Reviewed by Blenis, 
1993, and Cobb & Goldsmith 1995). Ligands cause receptors to autophosphorylate on
22
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tyrosine residues; the phosphotyrosine residues of autophosphorylated receptors then 
bind the SH2 domains of adaptors, such as Grb2. The adaptors recruit guanine 
nucleotide exchange factors with proline-rich SH3 domain-binding sites to the 
membrane in proximity to the proteins they activate. Exchange factors promote the 
association of Ras with GTP which then binds the protein kinases Raf-1 and B-Raf, 
thereby targeting one or both Raf isoforms to the membrane where Raf-^MEK protein 
kinase activity is increased (Reviewed by Cobb & Goldsmith 1995). The diagram 
overleaf shows schematically the MAP-Kinase activation cascade (Figure 1.5).
Tyrosine kinase 
receptor GPGR
Growth
factor
ArrestinADAM
\ /J \ \
CAMP
Ras GEF 
SOS I  PKC I  I  PKA
Figure 1.5. The activation pathwav of MAP-K. Multiple pathways linking 
tyrosine kinase receptors and G-protein coupled receptors to MAP-K. 
Arrows indicate positive stimulation and blocked lines inhibition. The 
nvolvement o f  She, Grb2, Ras, Raf, and MEK, is also shown. (Adapted from 
Gutkind 2000)
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Activation of Ras can be achieved through recruitment of Grb2 by She (Pellici et al., 
1995) and Gabl (Nguyen et al., 1997). Mutations of the multisubstrate docking site of 
hepatocyte growth factor receptor although removing the ability to recruit Grb2, could 
still mediate Ras signalling through other proteins such as Gabl, PI3-Kinase, SHP-2 
and She (Tulasne et al., 1999) suggesting once more that activation of Ras is complex 
and depends on cell type and other factors (Downward, 1998 for review). 
Transcription of a set of “immediate early” genes is activated within minutes of a cell 
being stimulated by a growth factor. Activated MAP-Kinases translocate from the 
cytosol into the nucleus and phosphorylate various targets including Elk-1, thereby 
activating it to turn on the transcription of the fos  gene. In addition MAP-Kinases may 
phosphorylate the JUN protein which combines with the newly made Fos protein to 
form an active gene regulatory protein complex called AP-1. The AP I protein 
complex turns additional genes, although its exact role in stimulating cell proliferation 
remains to be defined (Figure 1.6).
! I 1
I \  /
RSK
TCP jun[vJUNj ATF2jM EF2 MEF2fos,CREI
Figure 1.6. Activation of Immediate earlv genes, c-fos, and c-iun. 
Arrows indicate positive stimulation and dashed lines interactions 
which are not established. (Adapted from Gutkind 2000)
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1.6 Hepatocyte Growth Factor (HGF):
Hepatocyte growth factor is a polypeptide mitogen originally shown to induce cell 
proliferation in hepatocytes. It was isolated from the serum of partially 
hepatectomised rats, and it is produced predominantly in the liver and the pancreas. 
HGF is produced by a number of cells (Hartmann et al., 1992). While this molecule 
is associated with modulation of functions related to hepatocyte proliferation, its 
synthesis within the liver occurs in non-parenchymal Ito cells rather than hepatocytes 
(Zamegar et al., 1990 and Defrances et al., 1992). HGF can be isolated from human 
serum and is also produced by the HL-60 (Histiocytic Leukemia) cell line (Nakamura 
et al., 1987).
HGF consists of two subunits held by a disulfide bond. The alpha subunit is 
composed of 440 amino acids and the beta subunit of 234 amino acids. HGF beta- 
subunit shows approximately 38% homology to the serine protease domain of 
plasminogen. HGF is synthesized as a single chain precursor (approximately 90 kDa) 
of about 728 amino acids, is biologically inactive, and is localised mostly on the cell 
surface and in the extracellular matrix (Mizuno et al., 1993; Bardelli et al., 1994). 
The inactive single chain precursor of HGF secreted by the producing cells is 
converted to a biologically active heterodimer by a serine protease (HGF-activator). 
Its activity is induced in injured liver tissue. Maturation of the precursor into the 
active hetero-dimer takes place in the extracellular environment and results from 
proteolytic cleavage by urokinase which acts as a HGF convertase (Naldini et al.,
1992). The mature form produced following proteolytic cleavage is composed of a 69 
kDa p-subunit (containing four kringle domains) and the 34 kDa p-subunit, similar to 
the catalytic domain of serine proteases, but with inactivating amino acid substitutions 
in the active site (Nakamura 1991 and Mizuno et al., 1992).
The HGF gene is a single copy gene, located on chromosome 7ql 1.1-21 in humans, 
and consists of 18 exons and 17 introns which span approximately 70 kb (Seki et al.,
1991). Its organisation highly resembles that of factors implicated in blood 
coagulation and fibrinolysis, such as prothrombin and plasminogen respectively. The 
primary structure of HGF is >90% homologous in humans and rodents (Zarnegar et 
al., 1992).
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HGF is also referred to as Scatter factor (SF), because it has been shown that it 
influences the motility of cells at picomolar concentrations. It disrupts desmosomal 
junctions between epithelial cells and induces a motile fibroblast-like phenotype. The 
factor also causes invasive growth of tumor cells, derived from epithelial cells and 
may also be involved in the process of wound healing and early embryonic 
development (Weidner et al., 1990). For some mammalian epithelial cells, scatter 
factor is merely a motility factor. The effects of HGF in normal and transformed cells 
are summarised in Table 1 :
Table 1. Effects of HGF in Normal and Transformed Cells
B-lymphoblasts, human 
Bronchial cells, neoplastic 
Epidermoid carcinoma, A431 
Endothelial cells 
Hepatocytes,primary rodent
Hepatoma cells (HepG2,Fao)
Liver epithelial cells, immortalized
Mammary gland epithelial cells
MDCK cells
Monocytes J-111, human 
Non parenchymal liver cells
Oral squamous carcinoma cells
growth inhibition
Proliferation
Proliferation, motility
Proliferation, motility
Proliferation, inhibition of cellular
communication
growth inhibition, motility
Transformation
formation of duct-like structure
branching morphogenesis, motility
increased motility 
Proliferation, scattering.
Migration, invasion
Tajima 1992 
Tajima 1992 
Tajima 1992 
Bussolino 1992 
Zarnegar 1995
Tajima 1992
Kanda 1993
Yang 1995
Weidner 1990
Tajima 1992 
Kan 1991
Matsumoto 1991
The region within the 32-212 N-terminal residues of HGF, termed HGF-NKl, 
constitutes its binding determinant (Lokker et al., 1994). Within this sequence, F162 
is crucial in maintaining the hydrophobic core of the first kringle (Rubin et al., 1991). 
Recombinant HGF-NKl competes for binding to the HGF receptor Met, on A549 
human lung carcinoma cells. However, Met autophosphorylation is inefficient and 
mitogenesis is not induced, even at very high concentrations of rHGF-NKl (Lokker et 
al., 1994). HGF is also involved in the development of the renal collecting system via 
autocrine and/or paracrine mechanisms (Woolf et al., 1995). In mouse embryos 
homozygous for a mutant HGF gene, placental and liver development is impaired, 
resulting in death in utero (Uehare et al., 1995 and Schmidt et al., 1995). These and
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Other data illustrate the role of HGF as a mesenchymal-epithelial mediator, targeting 
cellular activities such as mitogenesis and morphogenesis in a variety of normal and 
transformed cells.
1.7 The HGF Receptor
fhe HGF receptor is encoded by the c-Met proto-oncogene (p i90^^') (Weidner et al., 
1991, Bottaro et al., 1991). The gene for c-Met is located on human chromosome 
7pl 1-4 and encodes a protein with intrinsic tyrosine-specific protein kinase activity in 
its intracellular domain. Met belongs to a subfamily of the heterodimeric tyrosine 
kinases, which also includes the receptors Ron, and Sea (Huff et al., 1993, Gaudino et 
al., 1994).
Proteolytic ^ iM v o g o
HGF
Inacthro H GF A ctivoH G F
MET
Ditulphid* bonds
P subunit 
U SkD a
a  subunit 
45 SO kD a
Tyrosine K inase Domain
Figure 1.7. Structure of HGF receptor. The alpha (light blue) and beta (dark 
blue) subunits are linked by two disulphide bonds (black). The C-terminal 
cytoplasmic domain encompasses a tyrosine kinase domain (yellow). The 
main downstream adapters and transducers are also shown.
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The transmembrane Met protein (pl90 alpha/beta) consists of a heavily glycosylated 
45-50 kDa (alpha) and a 145 kDa (beta) subunit linked by two disulphide bonds. The 
alpha subunit is extracellular and the N-terminal end of the beta-subunit is also on the 
extracellular side. The C-terminal cytoplasmic domain of the beta-chain encodes a 
tyrosine-specific protein kinase (Figure. 1.7). Both subunits originate from 
glycosylation and proteolytic cleavage of a common precursor of 170 kDa. Truncated 
forms of the Met protein (130 kDa and 140 kDa) lacking the intracellular tyrosine 
kinase domain have also been described. HGF binding triggers tyrosine 
autophosphorylation of the p-subunit and it enhances its enzymatic activity 
(Comoglio 1993).
Tyrosine phosphorylation of the Met receptor by HGF transduces inhibitory signals 
regarding mitogenesis in Meth A cells (Komada et al., 1992). The scattering effect of 
the activated Met receptor is transduced through the cytoplasmic domain by activation 
of its tyrosine kinase activity, as demonstrated in the B16-F1 mouse melanoma cell 
line transfected with a chimeric receptor (Komada et al., 1993). Transfection with the 
native heterodimeric receptor, the p-chain homodimer or a mutant receptor lacking 
kinase activity does not transform rodent fibroblasts (Zhen et al., 1994).
Although the Met transfectants exhibit anchorage-independent growth, they do not 
form foci in confluent cultures and are not tumorigenic in nude mice (Giordano et al.,
1993). However, deletion of the transmembrane region results in the acquisition of 
constitutive kinase activity by the cytoplasmic domain, leading to the formation of 
foci and development of tumours. Substitution of a lysine residue responsible for ATP 
binding results in impairment of the catalytic function and transforming capacity 
(Zhen et al., 1994). The transforming capacity of murine Met was found to be 
substantially greater than that of the human counterpart and co-expression of Met and 
HGF led to efficient tumorigenesis (Rong et al., 1992).
The first 39 amino acids of the juxtamembrane domain and the regulatory tyrosines in 
the catalytic domain are essential for maintenance of such transforming capacity. It 
can be concluded that Met-transfected fibroblasts predominantly express a mitogenic
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and invasive, rather than a proliferative, phenotype. Over-expression of the HGF 
receptor has been observed in a variety of human tumours (Table 2).
Table 2: Human tumours over-expressing c- Met.
Gastrointestinal carcinoma Kitadai 1993
Glioma, human Moriyama 1995
Hepatocellular carcinoma Selden 1994
Lung carcinoma Liu 1993a,b
Lymphoma, human Jucker1994
Melanoma, human Saitoh 1994
Osteosarcoma Ferracini 1995
Ovarian cancer DiRenzo 1994
Pancreatic cancer Tahara 1995
Prostatic carcinoma Humphrey 1995
Thyroid carcinoma DiRenzo 1995
Under physiological conditions, the intrinsic protein kinase activity of Met is 
activated only by binding of the ligand (HGF) to the receptor, leading to its 
autophosphorylation. Different models of stimulation of tyrosine kinase activity by 
receptor dimerization have been proposed, (Hubbard et al., 1998) the more recent 
(Schlessinger, 2002) based on structural studies is shown below (Figure. 1.8)
The tyrosine phosphorylated receptor also phosphorylates various other cytoplasmic 
signal transducers and adaptors, including the 85 kDa subunit PI3-Kinase, rasGAP, 
Phospholipase-C-gamma (PLC-y), She, Grb2-Sos, and Fyn (a tyrosine kinase of the 
Src family) (Bardelli et al., 1992, Matsumoto et al., 1994). Upon ligand binding and 
subsequent dimerization of Met, several tyrosine residues in the intracellular region of 
the beta subunit become phosphorylated and (Ponzetto et al.,
1993, Zhu et al., 1994 and Weidner et al., 1996). and Y^ ^^  ^ are the major
29
Chapter I_________________________________________________________________ Introduction
autophosphorylation sites within the beta-subunit and their mutation abolishes the 
biological activity of Met (Longati et al., 1994).
B
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Figure 1.8. Model for Receptor-Mediated Mechanism of EGF Receptor 
Dimerization. (A) The crystal structures describe the ligand binding domain 
o f  EGF receptor in complex with EGF or TGFa. Receptor dimerization is 
mediated by a protrusion in domain II (dimerization loop, red colour) that 
interacts with a specific region in the adjoining receptor to bring about 
receptor-receptor interactions. It is assumed that the dimerization loop in the 
unoccupied receptor adopts a conformation (colored blue) that does not 
facilitate receptor-receptor interactions. In addition, intramolecular domain 
II-IV interactions may also maintain the EGF receptor in an inactive state. 
(B) Alignment o f  the amino acid sequence o f  the dimerization loop o f EGF 
receptor (marked by arrows) with the corresponding sequences in ErbB2, 
ErbB3, and ErbB4. The residues in red and blue mark amino acids that is 
identical in three or two members o f  the EGF receptor family, respectively. 
(Adaptedfrom Schlessinger, 2002)
Transduction of Met signals depends on ligand-induced phosphorylation of two 
tyrosine residues within a bidentate motif located in the beta-subunit carboxy-
30
Chapter I Introduction
terminal, (docking site) of mixed specificity (Y'^"^/VHVNATY"^''/VNV) (Ponzetto 
et al., 1994, Fixman et al., 1995). These phosphotyrosines are responsible for 
recruiting proteins (adaptors and transducers) known to interact with Met. More 
precisely, it was found that Grb2 is only recruited by (Songyang et al., 1993, 
Maina et al., 1996), whereas seven distinct proteins ppbOsrc, PI3-Kinase, PLC-y, She, 
SHP-2, Gabl, and STAT3) are recruited by both and All these signaling 
molecules bind phosphorylated tyrosine residues via their respective Src homology 2 
domains (SH2), except for Gabl, which binds via a novel Met-binding domain 
(MBD) (Weidner et al., 1996, Schraeper et al., 2000).
1.8 The Grb2 Adaptor
The Growth factor receptor bound protein 2, (Grb2) is an adaptor protein made up of 
one SH2 domain flanked by two SH3 domains (see section 1.4). It is a small protein 
of 217 a.a. (25 kDa) and its structure has been solved (Maignan et al., 1995). The SH2 
is separated from the SH3’s by two flexible arms (linkers) (Figure 1.9).
Figure 1.9 Growth 
factor receptor bound 2 
protein. Grb2 Crystal 
structure at 3.1 A 
resolution. Showing 
SH2 domain sperated 
from the SH3’s by two 
flexible arms (linkers). 
(Adapted from Maignan 
et al. 1995).
Grb2 binds certain phosphotyrosine proteins through its SH2 domain, while its SH3 
domains may interact with specific proline-rich motifs on other proteins. The structure 
of the SH2 domain is not affected, by the adjacent SH3 domains and the biochemical
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properties of the isolated SH2 domain (as discussed in sections 1.3 and 1.4) are 
identical with the properties of SH2 domain when present in complete Grb2 (Cussac 
et al., 1994). Grb2 is regarded by many as an adaptor protein responsible for the 
activation of Ras through its interaction with Sos. However the role of Grb2 is not 
well defined even in the context of the Grb2-Sos interaction and the precise role of 
Grb2 is still a matter of debate (Chardin 1995, Buday 1999 for review).
Grb2 Homologues
Sem-5, the Grb2 homolog from Caenorhabditis elegans, is 58% identical to human 
Grb2 and was discovered as a gene involved upstream of Ras in the Let-23 receptor 
tyrosine kinase signalling pathway that controls vulval development and sex myoblast 
migration (Lowenstein et al., 1992). Several mutants of the SH2 and SH3 domains 
have been isolated (Clark et al., 1992). These are the P49L, E89K, S90N and the 
G203R. The P49L is an N-terminal SH3 domain mutant, which mutates the ligand 
binding site therefore decreasing the affinity for proline-rich ligands and it is a severe 
mutation. Only 9% of the larvae develop to adults and all are of the vulvaless 
phenotype. The E89K (Glu pB8) and S90N (Ser loop B-C) mutations in the SH2 
domain are much milder, there is no lethality, and a vulvaless phenotype is only 
observed in only 11% of the cases. Interestingly the G203R mutation in the C- 
terminal SH3 domain, does not lead to a vulvaless phenotype, and it is much milder 
than the P49L mutation (Chardin 1995, Downward 1994). These observations have 
led to the suggestion that the Sem-5 C-SH3 domain is less important than the N-SH3 
domain for signal transduction, most likely because the G203R mutant is still able to 
interact with Sos (Xie et al., 1995). The Sevenless signalling which initiates R7 
photoreceptor maturation in Drosophila eye development, triggers a phosphorylation 
cascade that activates transcription factors and modifies cell cycle regulation. The 
Grb2 homolog, DRK (Downstream of receptor kinase) binds to phosphorylated 
Sevenless, and participates in building a protein complex associated with Sevenless 
that includes the SOS (Son of sevenless) and Ras (Simon et al., 1993). Two mutants 
that disrupt signalling downstream of the sevenless receptor tyrosine kinase have been 
isolated, R67H and H106Y. These are mutations in the SH2 domain, and both affect 
directly the phosphotyrosine binding site. Loss of function mutants lead to high
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mortality at the larval stage (Chardin et al., 1995). The fact that Grb2 makes 
complexes with the Ras guanine nucleotide release protein Sos and transmits signals 
from tyrosine kinases to Ras has been convincingly demonstrated (Olivier et al., 1993, 
Simon et al., 1993, Clarck et al., 1992). In mammalian systems, the SH2 domain of 
Grb2 has been shown to bind directly to the EGF receptor, or to form a complex with 
other linker proteins, like She. The ultimate effect of these Grb2-mediated complexes 
is to bring Sos to the plasma membrane, where it activates Ras (Rozakis-Adcock 
1993).
Binding Partners of Grb2
Because of its structure, Grb2 can associate with many proteins and therefore may 
also serve as a linker protein in many signaling pathways. A large number of tyrosine 
phosphorylated proteins have been identified as binding partners of the Grb2 SH2 
domain. A few are listed below (Table 3).
Table 3. Trans-membrane tyrosine phosphoproteins known to associate 
directly with the SH2 domain of Grb2
P H O S P H O P R O T E IN B IN D IN G  SIT E R E F
c-M et Y 1 3 5 6  (Y V N V ) M aina 1 996
E G F  R ecep tor Y 1 0 6 8  Y 1 0 8 6  (Y IN Q , Y H N Q ) B u d ay  1993
C D  28 Y 1 0 7  (Y M N M ) K im  1 9 9 8
c-F m s (C S F -1  R ecep tor) Y 6 9 7  (Y K N l) V an  der G eer
T E K Y l l O l H u an g  1995
c-K it (S C F  receptor) 9 B lu m e Jen sen
Although direct binding of Grb2 to activated autophosphorylated receptors such as 
Met occurs, Grb2 and Grb2-complexes can be recruited to the receptor through 
additional tyrosine phosphorylated linker molecules. Two such linker molecules have 
been identified: She and SHP-2. Upon ligand stimulation, most receptor tyrosine 
kinases examined to date have been able to induce tyrosine phosphorylation of She,
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which subsequently binds to the SH2 domain of Grb2. She interacts with 
autophosphorylated receptors through its PTB domain (Isakoff et al., 1996) and 
tyrosine phosphorylation of She at Tyr 317 provides a docking site for Grb2 
(VanderKuur et al., 1995). Interestingly She itself can be recruited to the 
autophosphorylated EGF receptor by either a direct or an indirect mechanism 
suggesting that multiple routes can mediate membrane translocation of Grb2 (Buday 
et al., 1993, Batzer et al., 1994).
The other frequently reported SH2/binding partner of Grb2 is the protein tyrosine 
phosphatase SHP-2, also known as Syp, PTPID, or SHPTP-2. SHP-2 is a 70 kDa 
protein which was found to be tyrosine-phosphorylated in response to PDGF 
stimulation (Li et al., 1994). Grb2 is unable to bind directly to the autophosphorylated 
PDGF receptor, and it was suggested that SHP-2 binding via its SH2 domain to 
pY1009 in the PDGF receptor, can link Grb2 to PDGFR signalling (Li et al., 1994). A 
number of membrane-bound tyrosine phosphoproteins are now known to associate 
indirectly with the Grb2 adaptor through these two linker proteins (Table 4).
Table 4. Tyrosine phosphorylated receptor proteins known to associate 
indirectly with the SH2 Domain of Grh2.
P H O S P H O P R O T E IN Linker Protein R E F
B -c e ll  receptor S he S m it 1 9 9 6
E rbB -3 S he F e d i 1 9 9 4
E rythropoietin  receptor S H P -2 T a u c h i1 9 9 6
F C y R l S he Park 1 9 9 6
FG F  recep tor-1 S he K lin t 1995
O H  R ecep tor She V anderK uur 1995
H E R /N eu S he X ie  1995
P D G F S H P -2 L i 1 9 9 4
Apart from the binding partners of SH2 domain and its indirect associations, a 
plethora of binding partners is also known for the SH3 domains. The proline-rich 
proteins known to bind to the SH3 domains of Grb2 are summarized in Table 5.
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Table 5: Proteins known to bind to the SH3 domains of Grb2 (Table adapted from 
Budav 1999)
Protein Reference
Cbl Buday 1996
CD28 receptor Okkenhaug 1998
C3G Tanaka 1994
Disabled (Dab-2) Xu 1998
Dynamin Gout 1993
Dystoglycan Yang 1995
N-WASP Miki 1996
POB-1 Ikeda 1998
P145 McPherson 1994a
Ptpld (SHP-2) Wong 1996
PTPa Den Hertog 1996
PTP-PEST Charest 1997
Reps 1 Yamaguchi 1997
SAM68 Fusaki1997
SOS Buday 1993
Synapsin McPherson 1994b
Vav Ramos-Morales 1995
Of course this is only a summary of the binding abilities of Grb2 because Grb2 can 
bind and form complexes via other linker molecules with an extremely high number 
of proteins (for reviews see Buday 1999, Ladbury 2000). Recently it has also been 
shown that Grb2 can associate with cortactin via the C-SH3 domain, following HGF 
stimulation (Crostella et al., 2001).
1.9 Interactions of Grb2 with Sos
Sos (named for the son of sevenless gene) is a 170 kDa guanine-nucleotide exchange 
factor for RAS (Rozakis-Adcock et al., 1993). Sos was first identified in Drosophila
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melanogaster, in which genetic studies showed that Sos is downstream of both the 
Sevenless and EGF tyrosine kinases. Sos is ubiquitously expressed in mouse and 
human tissues and two mammalian homologues of Sos have been cloned. Although 
the two mammalian Sos proteins, Sosl and Sos2, are related, the binding affinity of 
Sos2 is higher for Grb2 in comparison with that of hSos2 both in vitro and in vivo. 
The region conferring this higher affinity has been mapped to residues 1126-1242 of 
the hSos COOH-terminal domain. This suggests that Sosl and Sos2 may differentially 
contribute to receptor mediated Ras activation (Yang et al., 1995)
The Grb2-Sos complex preexists in non-stimulated cells (Egan et al., 1993a) and upon 
stimulation is recruited to the plasma membrane by an activated receptor or docking 
protein to form a tertiary complex (Lemmon et al., 1994b). Several mechanisms have 
been proposed. The simplest is that it is brought into close proximity to its target Ras 
which is associated with the plasma membrane. Associated molecules, such as She, 
and SHP-2, are believed to translocate the Grb2-Sos complex to the plasma 
membrane. The resultant increase in the local concentration of Sos experienced by 
Ras leads to a higher exchange of its GDP for GTP, resulting in Ras activation (Gale 
et al., 1993, Rozakis-adcock et al., 1993, Li et al., 1993). Ras, in turn, activates the 
serine/threonine kinase Raf. Raf phosphorylates and activates the dual specificity 
kinase MEK which then phosphorylates and activates the MAP kinases ERK 1 and 2, 
(Cherniack et al., 1994), and thus induces the activation of transcription factors such 
as/os or jun as illustrated in Figure 1.6.
Binding studies of Grb2 to an EGF receptor-derived phosphotyrosine-containing 
peptide and a Sos-derived proline-rich peptide using isothermal titration calorimetry 
and surface plasmon resonance measurements, concluded that there is no allosteric 
communication between the SH2 and SH3 domains of Grb2 (Lemmon et al., 1994). 
Similar reports state that binding of the Grb2 SH2 domain to phosphotyrosine motifs 
does not change the affinity of its SH3 domains for Sos proline-rich motifs (Cussac et 
al., 1994). Because the Grb2-Sos complex appeared to be very tight (Lemmon et al., 
1994, and Cussac et al., 1994), and the affinity of hSos peptide for Grb2 was 
surprisingly low it was also suggested that additional interactions are likely to exist 
between Grb2 and hSos. Together with this observation, it has also been suggested 
that the amino terminus of Sos, which contains Plectrin Homology (PH) and Dbl
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homology (DH) domains is essential for its function in Drosophila and a mutant 
molecule lacking the amino terminal was found to be a potent dominant-negative 
inhibitor. Furthermore, the proline-rich C-terminal part of the protein was not 
necessary for the membrane translocation of Sos.
Additional data have underlined the importance of the N-terminal domain of Sos in a 
number of other systems. In these studies, various truncations and mutants of Sos 
were tested for their ability to activate Ras. These studies suggest that the PH domain 
of Sos may play a role in the translocation of Sos to the membrane. Although the 
exact function of the PH domain is not known the full N-terminal domain is essential 
for stable membrane localization of Sos and Ras activation (Buday 1999 and 
references within). Another interesting point is the demonstration (Vidal et al., 1998) 
that a proline-rich peptide derived from Sos blocks the formation of the Grb2- 
Dynamin complex, while the proline-rich peptide of Dynamin is unable to inhibit the 
Grb2-Sos recognition, suggesting that an increasing concentration of Sos might 
locally displace the Grb2-Dynamin complex in cells containing such a preformed 
complex. Freeing Dynamin from its complex with Grb2 might decrease its GTPase 
activity, and thus promote other signalling pathways.
Nonetheless, these results provide evidence of an interconnection between both 
activation and deactivation of Ras pathways. It is noteworthy that the sequence that 
plays a critical role in the interaction with Dynamin is in the N-SH3 terminal 
suggesting once more that N-SH3 is more important than C-SH3 for signal 
transduction (Vidal et al., 1998).
1.10 Interactions of Grb2 with She.
She stands for SH2 domain containing a2 Collagen-related proteins. The She family 
consists of three polypeptides, p46^^^, p52 and p66^^ .^ She proteins of 46 and 52 
kDa encoded by a 3.4 kilobase mRNA are ubiquitously expressed, whereas the 66 
kDa She protein is likely encoded by a distinct transcript and is absent in some 
haematopoietic cells (Pelicci et al., 1992). She contains two different 
phosphotyrosine-recognizing regions: a C-terminal SH2 domain and a PTB domain at 
the N-terminus of the molecule (Figure 1.10).
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SH2
Figure 1.10 Structure of the She protein. 
Showing the SH2 and PTB domains.
PTB
Binding sites for the She PTB domain are found in several activated receptor tyrosine 
kinases and comprise the consensus L/IXNPXpY (Chardin et al., 1995, Batzer et al., 
1995). Synthetic peptides with this sequence bind specifically, and with high affinity, 
to the She PTB domain (Kavanaugh et al., 1995). Suggesting that the N-terminal 
PTB domain as well as the SH2 domain interact with tyrosine-phosphorylated growth 
factor receptors, in the assembly of different signalling complexes. (Kavanaugh, et al., 
1994, Egan et al., 1993a, Isakoff et al., 1996). The HGF receptor is known to 
associate with the She adaptor via its SH2 domain (Pelicci et al., 1995).
The docking sites for She in the HGF receptor are the phosphotyrosine residues 
within the motifs Y1349VHV and Y1356VNV. She is phosphorylated on Y317VNV, 
generating a high affinity binding site for Grb2 which duplicates the Grb2 site present 
on the HGF receptor (Pelicci et al., 1995). Grb2 binds to She via its SH2 domain, 
forming a Shc/Grb2/Sos complex, resulting in the recruitment of Grb2/Sos complexes 
on the cell membrane and Ras activation (Cussac et al., 1994).
Over-expression of the She adaptor in 3T3 cells, results in increased cellular 
proliferation and migration in response to HGF (Pelicci et al., 1995). She is also a 
good substrate for Src family kinases and, in v-Src and v-Fps expressing cells. She is 
constitutively tyrosine-phosphorylated and forms a complex with Grb2. (McGlade et 
al., 1992). She also complexes with the tyrosine phosphorylated P4 subunit of the 
alpha-6 beta-4 integrin (a member of the hemidesmosomes) followed by recruitment 
of Grb2. This association provides an additional linkage between cytoskeletal 
molecules and intracellular signal amplifiers (Shc/Grb2) (Mainiero et al., 1995). PI3-
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Kinase has also been shown to associate with She in cells transformed with the 
BCR/Abl oncoprotein (Harrison-Findik et al., 1995).
1.11 Interactions of Grb2 with PI3-KJnase
HGF acting through the Met receptor provides to date the best known physiological 
signal for cell scattering. Tyrosine 1356 in the carboxyl terminus in the Met receptor 
is essential for association with PI3-Kinase, Phospholipase-C y, and Grb2, suggesting 
that at least one of these signalling pathways is required for cell dissociation and 
scatter. However mutated HGF receptor (CSF-Met Y1356F) containing a substitution 
of a histidine residue for the asparagine downstream from tyrosine 1356 (N1358H), 
which failed to bind only the Grb2 adaptor protein, stimulated MDCK cell scattering 
in response to ligand, demonstrating that association of Grb2 with the Met receptor is 
not essential for this. Following stimulation with HGF, activation of PI3-Kinase, but 
not Phospholipase C-y or pp70^^^, a downstream target of PI3-Kinase, is essential for 
MDCK scattering through Rac and Ras (Royal & Park 1995).
Further experiments outlined that pathways downstream from PI3-Kinase are 
associated with cell dissociation and cell scattering, whereas pathways downstream 
from Grb2 are required for branching tubulogenesis in MDCK cells (Royal et al., 
1997). The observations that Ras interacts directly with the p i 10 catalytic subunit of 
PI3-Kinase, raises the possibility that PI3-Kinase may serve as an effector of Ras 
(Rodriguez-Viciana et al., 1994). Recently observations that PI3-Kinase can be 
downstream of Ras have been reported (Chan et al., 2002). PI3-Kinase acts through 
its lipid product, PIP3, to mediate activation of Rac downstream of many tyrosine 
kinase receptors (Nobes et al., 1995). It is thought that the lipid interacts with some 
PH domains found in GEFs and that this leads to relocalization and/or activation of 
Rac exchange factors. In addition, PI3-Kinase can itself interact directly with small 
GTPases. The p i 10 catalytic subunit interacts with the GTP-bound form of Ras, while 
the p85 regulatory subunit interacts with Cdc42 or Rac through a bcr GAP-homology 
domain (Zheng et al., 1994, Chan et al., 2002). Both interactions have been reported 
to lead to increased lipid kinase activity. The relationship between small GTPases and 
PI3-Kinase is, therefore, complicated since the latter can apparently act both upstream 
and downstream of Ras and Rac (Nobes et al., 1995). The synergy between Ras and
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Cdc42/Rac in regulating PI3-Kinase has not been explored. Overall, as illustrated in 
Figure 1.11, the potential complexity of cross-talk between Ras and Rac-dependent 
signals is striking. It is likely that only a subset of these connections are utilized in a 
given cell type in response to a specific agonist (reviewed in Wittinghofer 1995, Bar 
Sagi and Hall 2000).
PI 3-kinase Akt
/  %
Ras Rac
\  \
Raf < ----------------  PAK
\  /  
MEK1
I
ERK 
MAP kinase
Figure 1.11. Sisnal Conversence  
Downstream o f  Ras and Rac The Ras-Raf- 
MEKl-ERK MAP kinase cascade can be 
influenced by PAK-dependent phosphorylation o f  
either Raf or MEKl. PAK can be activated 
through a direct interaction with Rac or 
independent o f Rac via Akt. It seems unlikely that 
all these possibilities exist in the same cell at the 
same time and the pathway operating in any 
particular biological process will need to be 
defined. Solid lines represent direct protein: 
protein interactions and dotted lines represent the 
presence o f intermediate steps. (Adapted from 
BarSagi and Hall, 2000)
Only recently, for the first time it was shown by Park’s group (Royal et al., 2000) that 
HGF stimulation of epithelial MDCK cells leads within minutes to transient activation 
of the Rho GTPases, Cdc42 and Rac correlating with the induction of filopodia and 
lamellipodia by HGF. HGF stimulation of epithelial cells is accompanied by 
activation and translocation of downstream effectors of the Rho GTPases, PAK and 
Rho-Kinase. Their activation is critical for HGF-induced remodelling of the actin 
cytoskeleton, cell spreading and dissociation. Interestingly, HGF-dependent activation 
of Rac and lamellipodia formation is blocked in the presence of a PI3-Kinase inhibitor 
(LY294002). Although a precise mechanism has not been assigned yet, it is now 
certain that PI3-Kinase is required for MDCK cell spreading (Royal and Park 1995, 
Royal et al., 2000) and it has been shown that PI3-Kinase, kinase activity, is required 
for HGF-induced mitogenic signals in murine mammary carcinoma (SPl) cells 
(Rahimi et al., 1995). Additional information concerning the proteins that interact
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with PI3-Kinase is needed to define the biochemical interactions of PI3-Kinase that 
are involved in cell proliferation and cell shape.
It is also well known that the lipid products released by the PI3-Kinase activity, 
activate via PDKl the serine/threonine Protein Kinase B (PKB/Akt) which is an 
established survh al regulator (Rameh and Cantley 1999). Therefore implications of 
PI3-Kinase in cell survival provide evidence for additional protein interactions. Wang 
and co-workers 1995 (Wang et al., 1995) have shown that an interactor of p85 subunit 
of PI3-Kinase is Grb2 and the association is mediated by the SH3 domain of Grb2 and 
the proline-rich motifs flanking the Bcr homology region of p85. However this Grb2- 
PI3-Kinase interaction has not been confirmed by others and is still disputable (Dr. 
Feller personal communication). If however such interaction takes place it may allow 
Grb2 to link PI3-Kinase to receptors that lack the ability to bind PI3-Kinase directly 
such as GM-CSF. Alternatively the interaction between PI3-Kinase and Grb2 might 
use p85 to present Grb2 to activated receptors that otherwise lack access to the 
adaptor protein. Thus the interaction between PI3-Kinase and Grb2 has the potential 
to play a role in a variety of signaling processes.
The fact that only one SH3 domain of Grb2 is required for minimal binding to the 
p85a subunit of PI3-Kinase in vitro, raises the interesting possibility that Grb2 could 
use its free SH3 domain to bind to other factors. However it has been observed (Wang 
et al., 1995) that Sos is not bound in the same complex with PI3-Kinase. The 
possibility remains that another molecule could occupy the second SH3 domain and 
that would increase the signalling potential of the Grb2/PI3-Kinase system. Indeed, a 
number of interactions in the Grb2-PI3-Kinase motif have been reported, most 
importantly the Grb2/Gabl/PI3-Kinase although other possibilities have recently also 
been suggested (Gu et al., 2000, Lock et al., 2000, Schaeper et al., 2000, Ong et al., 
2001). There are many ways that PI3-Kinase can respond to HGF stimulation and an 
overview of the interactions of PI3-Kinase is outlined in figure 1.12:
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Figure 1.12. The interactions of PI3-Kinase in HGF-induced signalling. Grb2 
adaptor (colored purple), can associate with Gab 1/2 and subsequently entangle 
PI3-Kinase in a trimeric complex. Otherwise the Grb2 adaptor following its 
association with Sos results to the translocation of the multi-complex to the 
membrane, which results to subsequent association of PH domain-containing 
proteins, and the initiation of various cellular processes. (Adapted from Cantley 
LC 2002.)
1.12 Interactions of Grb2 and Met with Gabl.
Gabl docking protein was firstly identified and cloned, as a Grb2-associated protein, 
and was shown to undergo tyrosine phosphorylation in response to EGF and insulin 
stimulation. Gabl was subsequently isolated in a yeast two-hybrid screen for proteins 
capable of binding to the carboxyl-terminal tail of the hepatocyte growth factor 
receptor Met (Weidner et al., 1996). Gabl is tyrosine phosphorylated by Met and 
binds to Met via a novel Met-binding domain (MBD). In addition to the MBD 
domain, Gabl is also characterized by the presence of a PH domain. Upon its tyrosine 
phosphorylation, Gabl recruits a number of signalling molecules, by its multiple
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tyrosine phosphorylation sites that include three p85-PI3-Kinase binding sites 
(Holgado-Madruga et al., 1997), the adaptor protein She, the SH2 domain containing 
tyrosine phosphatase SHP-2 and SHIP, and a phosphatidylinositol 3,4,5-trisphosphate 
5- phosphatase (Lecoq-Lafon et al., 1999). Indirect association of Gabl with the Met 
receptor is also possible through a complex with adaptor molecule Grb2 (Bardelli 
1997, Nguyen et al., 1997) (Figure 1.13).
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Figure 1.13 Model for association of Gabl with Met, and involvement of Grb2. 
A and B, after activation of the Met receptor-tyrosine kinase, Tyr-1356 is 
phosphorylated and acts to recruit a Grb2-Gabl complex via binding of the Grb2 
adaptor protein SH2 domain to a consensus binding sequence downstream from 
Tyr-1356 (YVNV). The associated complex may be stabilized through an 
additional Gabl-mediated interaction with a phosphorylated Tyr-1349 residue. 
C, a Y1349F mutant retains high levels of association with Gabl (55% of wild 
type) mediated through a Tyr-1356-Grb2-Gabl interaction. D, a Y1356F mutant 
associates at a low level with Gabl (10% of wild type) through a possible direct 
association of Gabl with a phosphorylated Tyr-1349. (Adapted from Nguyen et al., 
1997).
The fact that efficient tyrosine phosphorylation of Gabl is dependent upon the ability 
of Tpr-Met (Tpr-Met oncoprotein consists of the catalytic kinase domain of Met fused 
downstream from sequences encoded by the tpr gene, and has constitutive kinase 
activity) to associate with Grb2 (Fixman et al., 1997) suggests that Gabl forms a 
complex with Grb2. Tpr-Met mutants with an impaired ability to couple with Grb2
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and to transform fibroblasts, fail to induce high levels of phosphorylation of Gabl, 
proving that Gabl functions as an important signal transducer for transformation by 
Tpr-Met (Fixman et al., 1997). Grb2 is believed to work synergistically with Gabl to 
facilitate recruitment to the Met receptor (Nguyen et al., 1997), and the association of 
Gabl with Y1349 has also been shown by Schaeper et al., 2000. It has also been 
shown that Gabl associates with PI3-Kinase and Grb2 in an unusual complex to 
promote cell survival by NGF (Holgado-Madruga 1997). Gabl associates with PI3- 
Kinase to activate mitogen activated protein kinase and jun-Kinase signaling 
pathways in EGF induced signalling (Rodrigues et al., 2000). However the exact 
mechanism and the presence or absence of Grb2 is not precisely identified.
1.13 Interactions of Grb2 and Met with Cbl.
The c-Cbl protooncogene product is a 120-kDa phosphoprotein that is tyrosine 
phosphorylated in cells transformed following activation of multiple receptor tyrosine 
kinases including Met (Fixman et al., 1997). The C-terminal portion of Cbl (Cbl-C) is 
primarily responsible for mediating protein-protein interactions. This region encodes a 
large proline-rich segment which contains multiple potential SH3 domain-binding 
sites that mediate the interactions of Cbl with proteins such as Grb2, Nek and Src 
(Meisner et al., 1995, Fukazawa et al., 1995, reviewed in Lupher et al 1998).
Cbl-C also encompasses the major sites of Cbl tyrosine phosphorylation, which 
function as docking sites for SH2 domain-containing proteins, such as Vav guanine 
nucleotide exchange factor, the Crk family of adapter proteins, and the p85 subunit of 
PI3-Kinase (Miyake et al., 1997, and Feller 2001 for review) Thus, the Cbl-C region 
mediates both constitutive associations with SH3 domain-containing proteins and 
activation-induced associations with SH2 domain-containing proteins. The N-terminal 
portion of Cbl has been highly conserved throughout evolution, implying that it is 
important for Cbl function and includes a RING finger domain. Recent studies have 
demonstrated that Cbl-N associates directly and selectively with a number of 
autophosphorylated tyrosine kinases (Miyake et al., 1997, for review), and is therefore 
referred to as the tyrosine kinase-binding (TKB) domain. (Figure 1.14)
44
Chapter I Introduction
G306E v-CW stop (357) 
\  702 del
SH2 \T  RF I
Cbl-N/TKB domain
CGrb2, N c i r a n d " " ^  Src family S H 3 ^
(7D0)YMTP <731)YEAM (774)YD'/P
(61^44)
PRO
Cbl-C
Figure 1.14 Structural d om ain s o f  C bl. A  sch em atic representation o f  the structural 
d om ains o f  hum an C bl and the b inding s ites for various sign a l transduction  proteins. 
T he C bl-N  (resid u es 1 -3 5 7 )  or tyrosin e k inase-b in d ing  (T K B ) dom ain  refer to  an 
integrated p hosp hop ep tide-b in d in g  platform  co m p osed  o f  a four-h elica l bundle (4 H ), a 
C a21-b in d in g  EF hand and an SH 2 d om ain . C bl-C  (resid u es 3 5 8 - 9 0 6 )  in clu d es a 
leucine zipper (L Z ), a proline-rich  region  (P R O ) and a RING  fin ger d om ain  (R F). 
B ind ing sites for SH 2 dom ain s (b lu e rectan gles) and SH 3 dom ain s (y e llo w  o v a l)  o f  
sign a lin g  proteins are sh ow n  ab ove the schem atic , as is the 14-3 -3 -b in d in g  region . T he  
p osition s o f  determ ined b ind ing s ites  for SH 2 dom ain s (a lo n g  w ith  the three C -term inal 
residues o f  the m otif) and 14-3-3 proteins are indicated . G 306E  points to  the T K B  
dom ain -inactivatin g  m utation an a logou s to  lo ss-o f-fu n ction  m utation in C aenorhabditis  
e leg a n s Cbl h o m o lo g  S L I-1 . v -C b l stop indicates the end o f  C bl found in the v-cb l 
o n co g en e  seq u en ces (eq u ivalen t to  C b l-N ). 70Z  del refers to  a 17-am in o acid  d eletion  
found in a potently o n co g en ic  m utant form  o f  C bl iso lated  from  the m urine pre-B ce ll 
lym phom a line 70Z /3 . (Adapted from Lupher et al 1998)
Cbl proline-rich repeats mediate its association with SH3 domains of Grb2, and high 
affinity binding of Cbl-Grb2 requires the N-SH3 domain of Grb2; however, after 
cross-linking with other molecules Cbl binds equally with the SH2 domain of Grb2. 
(for review Buday 1999). Moreover the identification of signaling pathways 
downstream of Grb2 shows efficient tyrosine phosphorylation of the Cbl proto­
oncogene product (Fixman et al., 1997). c-Cbl is involved in Met signaling in B cells 
and mediates HGF-induced receptor ubiquitination (Taher et al., 2002).
45
Chapter I__________________________________________________________________ Introduction
1.14. AIMS OF STUDY
A major issue in HGF/Met-induced signaling is the identification of adaptors and 
transducers which specifically transduce the development of a particular phenotype 
(proliferation, scattering and morphogenesis). Data from a number of laboratories has 
shown that mutation of Y1349 and Y1356 abolished Grb2 and PI3-Kinase binding, 
thus rendering the cells unable to develop any of the specified phenotypes in response 
to HGF (Royal et al., 1997, Bardelli et al 1999). Therefore it does appear that 
functional SH2 domains of Grb2 and of PI3-Kinase are required for a Met phenotype 
to develop. An issue which is unexplored is the identification of downstream 
pathways and effectors which could divert the cell towards a particular phenotype via 
coupling to the SH3 domains of Grb2. SH3-Grb2 domains have different binding 
properties and may therefore behave differently in the development of a HGF-induced 
phenotype.
The starting idea for this project was to investigate the involvement of the individual 
SH3-Grb2 domains in the development of a HGF-induced phenotype. Xie and co­
workers (Xie et al., 1995) have shown that A-N-Grb2 functions as a strong dominant- 
negative mutant which reversed the transformed phenotype induced by the mutation- 
activated HER-2/neu receptor tyrosine kinase in B104-1-cells (cells derived from 
NIH3T3 cells expressing the point mutation-activated HER-2/neu, figure 1.15).
In a more relevant study, Grb2 mutants (lacking SH3 domains) were also shown to act 
in a dominant-negative manner and reverted the phenotype of Tpr-Met-transformed 
fibroblasts. This was assigned to reduced activity of JNK (Jun N-terminal Kinase) 
(Rodriguez et al., 1997). We decided to study the involvement of the SH3 Grb2 
domains in the development of either HGF-induced phenotype (scattering, 
proliferation) and that was the basis of selecting the most appropriate cellular models. 
These included the A431 (human epidermoid carcinoma), the A549 (human small-cell 
lung carcinoma) and the NIH3T3 fibroblast cell lines, engineered to express full 
length Met. A431 and A549 cell lines undergo scattering and proliferation in response 
to HGF (Tajima et al 1992). A report from Comoglio's group has clearly shown that 
transfection of NIH3T3 fibroblasts with the Met oncogene resulted in a motile but not 
proliferating phenotype (Giordano et al 1993). NIH3T3 fibroblasts normally do not
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express the Met receptor, therefore, this cellular model would have been the most 
suitable to dissect motility-linked signalling.
pi 85pi 85pi 85
She She She
AN-Grb2
Figure 1.15 : H yp oth etic  w ork in g  m od es o f  w ild -tvp e  Grb2 and its S H 3 d om ain  d eletion  
in  B1Q4 m utants. Wild-type Grb2 (wt-Grb2) constitutively binds to Sos mainly through its amino- 
terminal SH3 domain. The Grb2/Sos complex is recruited to She that is tyrosine phosphorylated, 
leading to Ras activation. After introduction into the B104-1-1 cells, A-N-Grb2 can bind to She but 
not Sos. The Shc-A-N-Grb2 complex by itself is unable to trigger Ras activation. On the other hand, 
A-N-Grb2 sequesters She. Therefore, the endogenous wt-Grb2 cannot be recruited to She. Thus, A- 
N-Grb2 is a dominant-negative mutant of Grb2. In contrast, the A-C-Grb2 binds to Sos and She. 
The Shc-A-C-Grb2ISos complex can largely fulfil the functions of the Shc-wt-Grb2-Sos complex, 
leading to Ras activation. Since the recruitment efficiency of A-C-Grb2Sos by She is relatively 
lower as compared to that of the wt-Grb2Sos, Ras activation is slightly reduced in B104-1-1 
transfectant expressing the A-C-Grb2. In order to simplify the model, direct recruitment of wt-Grb2 
or A-C-Grb2 to the mutation-activated p i 85 is not included in this model. (Adapted from Xie et al 
1995).
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Experimental lines
The experimental lines to address these questions are:
Explore the effects of dominant negative Grb2 in the activation of Ras, MARK, 
JNK in response to HGF and measure the activities.
y Estimate the activity of PI3-Kinase in total phosphotyrosine, a-Met and a-Grb2 
immunoprecipitates. Does dominant negative Grb2 impairs the recruitment and 
activation of PI3-Kinase by the beta-subunit of the Met receptor?
Is disabled activation of PDKl and of PKB/Akt, resulting to a decreased cell 
survival?
Measure PKB/Akt activities in A431 cell lines expressing dominant negative 
Grb2; are these activities lower than those of parental cells?
^  Is a constitutively-expressed exogenous PI3-Kinase or PKB/Akt able to revert the 
apoptotic phenotype in response to HGF?
^  Is there a direct association between Grb2 and PI3-Kinase? Perform binding 
assays with GST-Grb2 and GST-PI3-Kinase proteins that will be generated for the 
needs of this poject.
^  Biological assays to estimate cell proliferation, scattering and invasion will be 
performed employing each individual cellular model (dominant negative Grb2- 
A431 and PKB/Akt/PI3-Kinase-expressing cells).
Assays to evaluate apoptosis will also be performed using commercially available 
systems (Apoalert).
An additional issue to be investigated within the grounds of the project is the up- or 
down-regulation of gene expression due to the dominant negative effects of mutated 
Grb2. If dominant negative mutant Grb2 causes deficient stimulation of the survival- 
linked PKB/Akt, this may also be accompanied by altered expression of genes 
directly or indirectly linked to apoptosis. It would therefore be worthwhile to 
investigate further this issue and my thought is to employ gene array technology. 
RNA will be prepared from the parental and generated cell lines and cDNA will then
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be synthesized and labelled. cDNA will be used to hybridise membranes with arrayed 
genes (Clontech) and phosphorimager analysis output will be produced in order to 
evaluate differential expression. Then differential expression of genes of interest will 
be further confirmed by RT-PCR. Other approaches could be employed, as discussed 
under the section of future work. The laboratory where this work was carried out had 
developed the technical tools and considerable expertise in gene cloning, cell 
transfections, recombinant proteins and immunoprécipitations, therefore these 
methods were employed for my research project.
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C h a p t e r  I I  
2. EXPERIMENTAL PROCEDURES
Detailed information on buffers, reagents, restriction enzymes and restriction enzyme 
buffers can be seen in appendix III.
2.1 Ceil Culture:
A431 and A549 cell lines were obtained from the Imperial Cancer Research Fund 
(ICRF, London) cell bank. They were grown in Dulbecco’s Modified Eagle’s medium 
(DMEM) supplemented with gentamycin (40 pg/ml) and 10% Fetal Calf Serum 
(Sigma). Medium was changed every second day and when required cells were 
trypsinized using Ix EDTA/Trypsin solution (Sigma). Cultures were maintained in a 
5% C02/95% humidified atmosphere.
2.2 Crvopreservation of cell lines:
Cells from a 90% confluent culture grown on 10cm dish were trypsinized for 5 
minutes at 37 °C, by adding 2ml of trypsin (Sigma) per dish. The cells were washed 
with DMEM, spun down and resuspend the cells in an appropriate volume (1ml 
contains 1-2 milion cells) of cryopreservation buffer, 10% DMSO, 20% DMEM and 
70 % Fetal Calf Serum. All the work was carried out in the vertical hood, cells were 
clearly labeled and the ampoules were stored at -70 °C for 24 hours and then moved in 
dry ice to the liquid nitrogen.
2.3 Thawing cells from liquid nitrogen;
The ampoule of interest was removed and transferred to a 37 °C waterbath. With 
slight rocking it was thawed as quickly as possible, and the content was transferred to 
a 10 cm dish together with 10 ml of DMEM supplemented with 10% FCS. Cells were 
incubated until confluency and the trypsinized and replated into one or more plates or 
flasks.
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2.4 HGF and cell stimulation:
Hepatocyte Growth Factor was a kind gift from Genentech, Inc, CA, USA. Confluent 
monolayers of A431 cells were cultured for 48 hours in media lacking fetal calf serum 
to reduce the background level of tyrosine-phosphorylated proteins. The cell medium 
was then replaced with DMEM, enough to cover the cell monolayer (10 ml was 
sufficient for a 75cm^ flask). The cells were stimulated with 100 ng/ml of HGF and 
incubated at 37 °C for 10 minutes. At the end of each time point after HGF 
stimulation the medium was tipped off, and the dish was placed in -70 °C until further 
processing.
2.5 Preparation of total cell Ivsates from cell lines;
Cells were rinsed to remove medium and were scraped using a cell scraper in 1-2 ml 
of ice-cold PBS. The scraped cells ware then transfered to 1.5 ml vials and spun 
briefly for 20 seconds. The supernatant was removed and approximately 300-500 pi 
of lysis buffer was added to the packed cells. The cells were resuspended with a 
pipette and passed 4-5 times through a 1 ml syringe equipped with a 26 gauge needle. 
The lysate was spun for 2 minutes to precipitate the debris and insoluble material. The 
supernatant was collected and the protein concentration of the lysates was estimated 
as described in 2.14 and the lysate was stored in aliquots at -70 °C until further use.
2.6 Protein Estimation:
The protein content of cell lysates was determined using the Coomassie blue reagent 
(Bradford method). The absorbance at 595 nm was read against a standard curve 
generated with serial dilutions of Bovine Serum Albumin 0-200 pg (see figure 2.5). 
The yield and purity of Sepharose-coupled GST-fusion proteins (Grb2, P13-Kinase) 
was determined by resolving GST-fusion proteins by SDS-PAGE 10% together with 
serial dilutions of commercial BSA (95% purity). Gels were then stained with 
Coomassie Blue (methanol 100 ml, acetic acid 100 ml coomassie blue 1 gram 
purchased from Sigma Cat No: B0149, and deionized water to 1000 ml) and the 
intensity of band staining was compared visually with that of the BSA (figure 2.1).
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A standard curve of Bovine Serum Albumin (BSA) against 
Absorbance at 595nm
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Figure 2.1 Standard curve of BSA used for protein 
estimation.
2.7 Antibodies:
Antibodies to Grb2 (host: mouse, raised against total Grb2, catalog No: G16720), 
Sosl (host: mouse, raised against NH2 conserved region, catalog No:S15520), PI3- 
Kinase (host: mouse, raised against C-SH2 terminal, catalog No:P13020) and She 
(host: rabbit, raised against C-SH2 terminal, catalog No:S 14630) were from 
Transduction Laboratories. (Lexington, KY). Two monoclonal antibodies against 
hemagluttinin (a-HA) were used, the mouse monoclonal antibody clone 12CA5, 
recognising the peptide sequence YPYDVPDYA, (catalog No: 1583816) and the a- 
HA antibody-Peroxidase, high affinity clone 3F10, (rat IgGl) recognising the peptide 
sequence YPYDVPDYA, (catalog No: 2013819) from Roche Molecular
Biochemicals. The latter recognises the same epitope as clone 12CA5 but its high 
affinity and low working concentration result in less cross-reactivity compared to 
other antibodies to the HA-epitope, and was especially used in western blots to allow 
specific and highly sensitive detection of HA-tagged proteins. Antibodies to Erk 1/2 
(a-PhosphoMapKinase clone 12D4, catalog No: 05-481) and a-Phosphotyrosine 
(clone 4G10, catalog No: 05-321) were purchased from Upstate Biotechnology (TCS 
Biologicals). Antibody to the Met receptor (h-Met) an affinity purified rabbit 
polyclonal (C-28 raised against a peptide mapping at the carboxy terminus of c-Met 
pl40 of human origin, catalog No: sc-161) was purchased from Santa Cruz
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Biotechnology (Santa Cruz, CA). Peroxidase-labelled a-mouse and a-rabbit 
antibodies were from Jackson Immunodiagnostics (U.S.A).
2.8 Immunoprécipitations:
Cell lysates containing Img of total protein were placed in a 1.5 ml microcentrifuge 
tube, and lysis buffer was added to make it up to 1 ml. Then the primary antibody was 
added at 4 pg/mg of protein. Following incubation on a rotating wheel at 4 °C, for 2 
hours, 50 pi of protein-A agarose was added for 30 minutes and rotation was 
continued. Then lysates were centrifuged for 2 minutes at maximum speed and the 
supernatant was discarded. Immunoprécipitation buffer (10 mM Tris-HCl, pH 7.4, 1% 
Triton X-100 (w/v), ImM EDTA, 0.2Mm sodium ortho-vanadate, 0.5% Nonidet P40, 
150 mM NaCl, ImM PMSF) was added up to 1ml and the solution was mixed by 
vortexing. The tube was centrifuged again, and the washes repeated twice. Proteins 
were then eluted by heating in 4x Laemmli sample buffer (62.5 Tris-HCl, pH 6.8, 
25% glycerol, 2% SDS, 0.01% bromophenol blue, Bio-Rad Cat No: 161-0737). The 
proteins were resuspended in approximately 10 pi of ddH20 and 5 pi of SDS sample 
buffer were added, and stored at -70 °C until further use.
2.9 Seperation of proteins bv SDS -PAGE:
Gel plates with spacers were assembled according to the manufacturers instructions 
and a 10% acrylamide gel was prepared (to survey proteins between 10-200 kDa) by 
adding on ice 2.75 ml of 30% acrylamide/ 0.8% bisacrylamide, 2.05 ml of 4x Tris- 
HCl/SDS pH 8.8, 3.45 ml of dHiO, 27.5 pi of 10% ammonium persulphate, and 15 pi 
of TEMED (Sigma). The mixture was poured with a 1 ml pipette between the 
assembled gel plates and overlayed with isopropanol. After polymerisation 
(approximately 30 minutes) the isopropanol was removed using a capelari tube 
connected to a 1 ml syringe, the gel was carefully rinsed with water and dried using 
pieces of filter paper. Then the stacking gel was prepared by mixing 1 ml of 30% 
acrylamide/0.8% bisacrylamide, 1.9 ml of stacking gel buffer, 4.4 ml of dHzO, 40 pi 
of 10% ammonium persulphate, and 20 pi of N,N,N',N'-tetramethyl-ethylenediamine 
(TEMED).
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The mixture was poured with a 1 ml pipette between the assembled gel plates and the 
gel comb was placed carefully to avoid air bubles being formed. After polymerisation 
the comb was removed, wells were aspirated and the gel was transferred in the 
electrophoresis chamber which was filled with SDS-PAGE buffer. Protein samples 
were loaded after heating at 100 °C for 5 minutes. The upper electrode chamber was 
connected at llOV for 10-15 minutes (until the protein blobs entered the stacking gel 
and the voltage was reduced to 90 V. When good separation of protein species was 
required the voltage was lowered to 50V. SDS PAGE was terminated 1 cm away from 
the gel bottom.
2.10 Western transfer;
Proteins were transferred to a nitrocellulose membrane using the semi-dry transfer 
procedure (Reaction Apparatus from Bio-Rad). Fifteen pieces of Whatman filter 
paper and a piece of Polyvinilydene difluoride membrane (PVDF) were cut to the 
same size as the gel. Six pieces of Whatman paper were immersed in anode 1 buffer 
(0.3 M Tris-HCl, 20 % MeOH) and another six in cathode buffer (25 mM Tris-HCl, 
40 mM amino caproic acid, 20 % MeOH) and three in anode 2 buffer (25 mM Tris- 
HCl, 20 % MetOH). The PVDF membrane was immersed in 100% methanol for 1.5 
minutes and rinsed for 2 minutes in dH2 0  before being immersed in anode 2 buffer. 
Then the gel was placed with the whatman papers and the PVDF membrane in the 
transfer apparatus as shown in figure 2.2
Anode 2
Anode 1
Cathode
PVDF
Figure 2.2. Schematic drawing of indicated blotting 
methods. Arrow shows the direction of transfer.
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Buffer excess was extracted by rolling a pipette over the entire pack; care was taken 
to avoid air bubbles, so as to ensure an even transfer (bubbles may cause localized 
non transfer of proteins). Then the lid was closed and transfer was set from the 
cathode to anode (-) to (+) for 1.5 hours at 40mA.
2.11 Western blotting:
After protein transfer the PVDF membrane was incubated in Ix PBS (Phosphate 
buffered saline) containing 0.1% (w/v) Tween-20 and 5 % BSA, for 45 minutes under 
gentle rocking. Then the blot was washed three times for 10 minutes with Ix PBS, 
0.1% Tween-20. The primary antibody was properly diluted in Ix PBS, 0.1% Tween- 
20 (total volume not exceeding 10 ml) and incubated with the PVDF membrane under 
gentle rocking for 1 hour at room temperature. Three washes with Ix PBS, 0.1% 
Tween-20, followed by addition of the secondary antibody diluted in Ix PBS, 0.1% 
Tween-20 and incubated under gentle rocking for 35 minutes at room temperature. 
The blot was washed again three times as above.
Reactive proteins were visualized using an enhanced chemoluminescence (ECL) kit 
(Pierce Cat No: 34080). Pre-mixed reagent was added onto each blot (enough to cover 
it completely) and after 5 minutes the reagent was tipped off, dried gently, and the 
blot was placed into an exposing cassette. ECL™ protein molecular weight marker 
was purchased from Amersham Biosciences (Cat No: PRN 2107). A mixture of six 
different proteins labelled with biotin for use in Western blotting following 
electrophoresis on a polyacrylamide gel prepared by the method of Laemmli 
(Laemmli 1970).
Incubation of the blot with streptavidin horseradish peroxidase followed by detection 
with the ECL Western blotting detection system results in a ladder of bands, on film, 
of approximately equal intensity. The molecular weights of these standards are not 
significantly altered by biotinylation. In the dark room a sensitive X-Ray film was put 
on top of the blot and developed quickly. For further probing blots were stripped in
62.5 mM Tris-HCl, pH:6.7, containing 2% Sodium Dodecyl Sulphate and 100 mM P- 
mercaptoethanol, for 30 minutes at 50 °C.
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2.12 Production of Giutathione-S-Transferase (GST) GST-Grb2 and GST-PI3- 
Kinase proteins;
Grb2 domains and full length Grb2 sub-cloned into pGEX-2T vector were kindly 
provided by Dr. H. Meisner (Harvard, MA, USA) and have been previously described 
(Meisner et al., 1995). The expressed GST-proteins are schematically represented 
below (figure 2.3).
Wt-Grb2 N SH3 SH2 C SH3
GST-SH2,C-SH3Grb2
SH2 C SH3
GST-SH2Grb2
SH2
GST-N,C-SH3Grb2
N S H 3 C S H 3
B
P85a
SH3 bcr SH2N iSH2 SH2C
GST-C-SH2p85
GST-SH3p85
GST-N-SH2p85
SH3
SH2N
SH2C
Figure 2.3 Expressed GST-proteins. Schematic representation of (A) the GST-Grb2 
proteins and (B) GST-PI3-Kinase p85a. The GST-fusion protein is not shown to 
simplify the diagram.
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Bacteria were grown overnight in flasks of LB supplemented with 100 pg/ml of 
ampicillin, with vigorous shaking. The 20 ml culture was diluted 1:10 by adding 
warm LB up to 200 ml and incubation was continued for 1 hour in a 0.5 L flask to 
ensure adequate aeration. IPTG was added to a final concentration of 0.1 mM and 
cultured again incubated at 32 for 2-6 hours. The culture was centrifuged at 4000 
rpm for 15 min to sediment bacteria. Bacteria were resuspended in 5 ml of ice-cold 
PBS, sonicated on ice in short bursts for 30 sec (total time). Then 20% Triton-X-100 
was added to a final concentration of 1% for 30 min to aid solubilization of the fusion 
protein.
The preparation was split into 1.5 ml vials and spun down at 13000 g for 5 minutes at 
4°C to remove insoluble material and unlysed cells. Supernatants were collected, 
pooled and added to Glutathione sepharose 4B. Up to 50 pi of Glutathione sepharose 
4B was added to 5 ml of sonicate and incubated with gentle agitation, at room 
temperature, for 30 minutes. After centrifugation at 800 g for 10 min the supernatant 
was removed.
The Sepharose was washed with 150 pi o f  PBS for 5 min. The suspension was 
centrifuged at 800 g for 2  min to sediment the matrix and the wash was repeated 
twice. The protein was resuspended in 500 pi of ice cold PBS. To elute GST protein 
the ependorf was spun down and 250 pi of 50 mM Tris-HCl pH 8.0/ 5mM reduced 
glutathione were added, mixed for 2 min and spun for 1 minute at 500 g. The 
supernatant was collected and elution was repeated twice, lowering the volume from 
250 pi to 50 pi. Proteins were stored in aliquots containing 10% glycerol at -70 °C.
2.13 Transformation of E.coii cells with plasmid DNA:
10 pi of competent E. coli cells (E. coli BL21 a protease-deficient E.coii strain for 
optimal expression of recombinant proteins was purchased from Amersham Cat No: 
27-1542-01) were transferred in a cold sterile 1.5ml microcentrifuge tube and mixed 
with plasmid DNA (3 pg) on ice. After gently mixing the cells were incubated for 30 
minutes on ice. Then they were heat-shocked for 2 minutes at 42°C in a waterbath, 
immediately transferred on ice, and left for 3 minutes. Then 800 pi of SOC medium 
(0.5% yeast extract, 2.0% tryptone, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCL,
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10 mM MgS0 4 , 20 mM sucrose) was added and incubated with vigorous shaking 
(225 rpm) at 37°C for 1 hour. Approximately 50-100 pi of this bacterial mix was 
plated on an ampicillin plate (Luria-Bertani agar plate with lOOpg/ml ampicillin) and 
left at 37 °C overnight.
2.14 Mini-prep of plasmid DNA bv boiling:
A single bacterial colony was inoculated at 5ml of sterile LB (Luria-Bertani) broth, 
and was left to grow overnight. Then 1.5 ml was transferred to a microcentrifuge tube, 
where it was microcentrifuged at maximum speed for 30 seconds. The supernatant 
was aspirated and the pellet was resuspended in 400 pi of STE buffer, (2 ml of 5M 
NaCl, 1 ml of IM Tris pH 8.0, 0.2 ml of 0.5 EDTA pH 8.0, and 96.8 ml of ddHzO) 
and was incubated for 5 minutes at room temperature. Then 35 pi from a 10 mg/ml 
lysozyme stock solution in buffer A (lOg sucrose, 1.25 ml IM Tris pH 7.4, 1.0 ml of
0.5 EDTA, made up to 50 ml with ddHzO) was added. The tube was incubated at 37°C 
for 5 minutes, boiled for 50 seconds in a heat block and placed on ice for 5 minutes, 
before being centrifuged at 4 °C for 15 minutes at maximum speed.
The supernatants were transferred into new microcentrifuge tubes where 500 pi of 
isopropanol were added and the tubes were incubated at room temperature for 15 
minutes. Then the tube was centrifuged for 5 minutes at maximum speed, the 
supernatant was carefully aspirated without disturbing the pellet, and 500 pi of 70% 
ethanol was added to wash the pellet. The tube was again centrifuged for 5 minutes at 
maximum speed, the ethanol was aspirated, and the pellet was dried using a speed- 
vac. The pellet was resuspended in 100 pi of TE buffer (lOmM of Tris-HCl pH 7.4, 
ImM EDTA pH 8.0) with RNase A (20 pg/ml).
2.15 M[idi-prep of plasmid DNA;
For the midi-preparation of plasmid DNA the Quiagen plasmid midi-kit was 
used (Cat No: 12143) together with the protocol described in the Quiagen 
plasmid purification Handbook for midi & maxi protocols July 1999 (Figure
2.4).
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Figure 2.4 Midi-prep of 
plasmid DNA, using the Quiagen 
plasmid purification kit.
Bacterial cells are lysed under alkaline 
conditions and the crude lysates are 
cleared using the QIAfilter Cartridge. At 
this stage, an incubation step with a special 
Endotoxin Removal Buffer can be 
performed for effective removal of 
bacterial lipopolysaccharides (EndoFree 
Plasmid Kits and Ultrapure 100 Column).
The cleared lysate is then loaded onto the 
anion-exchange tip where plasmid DNA 
selectively binds under appropriate low- 
salt and pH conditions. RNA proteins, 
metabolites, and other low-molecular- 
weight impurities are removed by a 
medium-salt wash, and ultrapure plasmid 
DNA is eluted in high-salt buffer.
Finally the DNA is concentrated and 
desalted by isopropanol precipitation and 
collected using the QIAprecipitator 
module.
2.16 Restriction Enzvme Digestion of Plasmid DNA:
In a 1.5ml vial, plasmid DNA, 1 pi of lOx Restriction Enzyme (RE) buffer, 1 pi of the 
appropriate restriction enzyme and sterile distilled water to make up a total volume of 
10-15 pi were added. These were mixed gently and incubated at 37®C for 1 hour. In 
the case where plasmid DNA was digested from mini-preps RNAse-DNAse-free (1 
pi) was added after 30 minutes and incubation was continued for additional 30 min. 
When DNA needed to be digested with an additional enzyme at the end of the hour 
lOx the RE buffer was added for the second enzyme (if different from the first one) 
and the second RE was added. Incubation was continued at 37°C for an additional 
hour. The restriction enzymes were purchased from Amersham Biosciences together
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with the appropriate restriction enzyme buffers. Enzymes used were Bgl I (cuts at 
GCCM HmiHGGC  Cat No: E1020V with basal buffer), Hind III (cuts at AMGCTT 
Cat No: E1060Y with medium salt buffer), BamHI (cuts at GiGATCC Cat No: 
ElOlOV with potasium salt buffer). Sail (cuts at G>lTCGAC Cat No: E1080Y with 
high salt buffer, see appendix III for details on buffers and enzymes).
2.17 Subcloning of Grb2 domains into mammalian expression vectors;
For my subcloning I used the pCGN expression vector which contains a beta-globin 
polyA site, followed by a hygromycin-resistance gene (kind gift of Sugen, CA, USA). 
Wild-type Grb2, A-N-SH3 Grb2 and A-C-SH3 Grb2 were subcloned in the BamHI 
site of pCGN and driven by the CMV promoter followed by an in-frame Influenza 
Hemagglutinin (HA) epitope tag (at the amino-terminus) (Figure 2.5). Wild type and 
Grb2 mutants in Bluescript were kindly provided by Dr. B. Mayer (Harvard, MA, 
USA). Plasmid constructs were characterized by restriction enzyme analysis and 
sequenced using specific primers. (Sequencing was carried out by research assistant 
S.Lidder)
Grb2/ pCGN
ORIHA epitope hygromycin M13/ORI
Amp RGrb2 beta-globin SV40 
Poly A
Figure 2.5 Expression Vector pCGN.
2.18 Transfections of cells with Grb2 constructs:
A549 and A431 cells were plated in 6 -well plates in FCS-supplemented DMEM and 
allowed to reach 60-70% confluency. Three hours before transfection, the medium
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was replaced. Transfections were carried out using the calcium phosphate kit from 
Promega and for generation of stable cell lines, 6 - 8  pg of DNA/dish/2 ml was used. 
Cells were incubated with the calcium phosphate/DNA precipitate for 12-18 hours. 
Then the cells were washed with pre-warmed Hanks solution (HBSS, Sigma) and 
grown for the next 24-36 hours in DMEM supplemented with 10% FCS and 
gentamycin. The medium was then replaced with DMEM containing either Geneticin 
(0418, Sigma) at concentrations between 500-1000 pg/ml or hygromycin B (Sigma) 
at concentrations between 300-400 pg/ml. A431 and A549 cells transfected with 
pCGN-Grb2 constructs undergone selection with Hygromycin B. Various 
concentrations of Hygromycin B were tested on the parental A431 aiming to 
determine the minimum concentration of the drug killing all plated cells. The 
concentrations recommended in the bibliography ranged between 300-500 pg/ml. A 
range of 300, 400 and 500 pg/ml were tested and concluded that 400 pg/ml was 
efficient in killing parental cells within 14-16 days. Cell clones were selected and 
propagated in a 24 well plate. When 90% confluence was achieved cells were 
transferred to a 6  well plate and subsequently grown in 1 0 cm plates and stored in 
liquid nitrogen until further use. The Wt-Grb2 contained all 217 aa, whereas Red is 
the A-N-SH3 58 aa deletion and blue is the A-C-SH3 60 aa deletion (Figure 2.6).
10 20 30 40 50 60
I I I I I I
M E A IA K Y D F K  A T A D D E L S F K  R G D IL K V L N E  ECDQNW YKAE L N G K D G F IP K  N Y IE M K P H PW
70 80  90 1 0 0  1 1 0  120
I I I I I I
F F G K IP R A K A  EE M L SK Q R H D  G A F L I R E S E S  A P G D F S L S V K  FG N D V Q H FK V  L R D G A G K Y FL
1 3 0  140  15 0  1 6 0  17 0  1 8 0
I I I I I I
W W K F N S L N E  L V D Y H R S T S V  S R N Q Q IF L R D  lE Q V P Q Q P T Y  V Q A L F D F D P Q  E D G E L G F R R G
190  2 0 0  2 1 0
I I I
D F IH V M D N S D  PNWWKGACHG Q T G M FPR N Y V  T P V N R N V
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GRB2
ÀN-SH3 GRB2
N-SH3
AC-SH3 GRB2 f
Figure 2.6 The Grb2 constructs. The Grb2 constructs used for generation 
of stable cell lines Wt-Grb2, A-N-Grb2, and A-C-Grb2, the 
Hemagglutinin (HA) epitope tag, is not shown.
2.19 Generation of MET-expressing NIH3T3 cell lines;
The Met-expressing NIH3T3 cell line (a kind gift of Dr. G. Skouteris, UCL Medical 
School, UK) was generated and evaluated as follows: NIH3T3 fibroblasts were grown 
in DMEM supplemented with 10% FCS as above. Full length Met was sub-cloned 
into pcDNA3 vector and transfections were carried out using the Promega kit, 
according to the manufacturer’s instructions. Transfected cells were cultured in 
DMEM containing 800-1000 pg/ml G418 and after 2-3 weeks clones appeared and 
analyzed for Met expression by Western blotting.
2.20 Evaluation of kinase activity of Met expressed in NIH3T3 fibroblasts:
Several clones were found to express full length Met and immune-complex kinase 
(ICKA) assays were carried out to test whether the expressed Met was an active 
tyrosine kinase. ICKA were carried out by immunoprecipitating 1-1.2 mg of total 
lysate protein from HGF-treated (100 ng/ml) or untreated lysates, with a- Met (Santa 
Cruz, rabbit polyclonal). The immunoprecipitated species were collected in Protein A 
Agarose beads, washed three times in lysis buffer and finally re-suspended in kinase
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assay buffer (25 mM HEPES, 2mM MgCb, 0.2 mM sodium orthovanadate) in the 
presence of lOpCi [y ATP], sp.activity >7000 Ci/mmol.
The assays were carried out for 20 min at room temperature (25 °C) and reactions 
were stopped by adding 4x Laemmli buffer. Phosphorylated proteins were eluted by 
heating the samples at 100 °C for 5 minutes and then analyzed by 10% SDS PAGE. 
Gels were wrapped and exposed to film for 5-30 minutes. The gels were recovered, 
electro-transferred and immunoblotted with a-Met (C28, Santa Cruz). The clones 
were found to express significant amount of Met which was also kinase active.
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C h a p t e r  I I I
3. RESULTS
3.1 Generation of Grb2 expression constructs
The expression plasmids generated were the pCGN-Grb2 (wtGrb2), pCGN-AN-Grb2 
and pCGN-AC-Grb2. After restriction enzyme analysis with BamHI, plasmids were 
prepared using a commercially available system as described in section 2.3 (Qiagen, 
midi and maxi-prep Kits) (Figure 3.1).
Wt-Grb2
D-N-Grb2
D-C-Grb2
/ / / /
Figure 3.1 Restriction 
Enzvme analysis. The 
three inserts can be seen at 
different positions due to 
their difference in sizes. 
The Wt-Grb2 migrates 
less as it is larger than A- 
N-Grb2 and A-C-Grb2. 
Also the A-C-Grb2 is 
slightly larger than A-N- 
Grb2 and migrates less 
than A-N-Grb2 giving this 
unique and distinctive 
pattern which represents 
Wt-Grb2 and its SH3 
domain mutants, (u) is for 
undigested samples and 
(d) is for digested
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3.2 Preliminary examination for choosing the appropriate cellular models
In order to choose the cellular models, a number of experiments were performed. The 
levels of Grb2 protein and expression of c-Met was assayed in the A431 (human skin 
carcinoma, epithelial like morphology) and A549 (human lung carcinoma, epithelial 
like morphology) cells. As control I used the Wt, SH2,C-SH3 and N,C-SH3 Grb2- 
GST-proteins (which are SH3 deletion mutants o f the Grb2 protein as explained 
previously) produced for the purpose of the project. From the results obtained, we 
deduced that Grb2 is present in higher amounts in A549 than in A431 cells (Figure 
3.2).
Grb2
1 2 3 4 5
Figure 3.2 Preliminary examination for choosing the appropriate 
cellular models. Assay of the levels of Grb2 in A549 and A431 cells. A431 
and A549 cell lysates containing equal amounts of total proteins were 
separated by SDS-PAGE and detected by Western blotting using a-Grb2 
antibody. Positive controls were the Wt, SH2,C-SH3 and N,C-SH3 GST- 
proteins (GST-eluted). Grb2 is present in higher amounts in the A549 cells 
(lane 5) than A431 cells.
Since the A549 and A431 cells are better characterized (than other cell lines) in 
relation to mitogenic response by growth factors and are also known to express Met, 
we decided to use A549 and A431 cells for the Grb2 transfections. Here it must be 
noted that a control o f a specific protein such as b-actin should be used for 
quantitation of loading. To verify that both proteins Grb2 and Met are adequately 
expressed in our cellular models, lysates of the selected cell lines A549 and A431 
were probed with antibodies to Grb2 and antibodies to Met (Figure 3.3).
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A549 
a-Grb2 | a-Met
Met 
140 kDa
Grb2 
24 kDa
Figure 3.3 Preliminary examination for choosing the appropriate 
cellular models. (A) A549 cell lysates containing 50 gg and 30 gg of 
total proteins were immunoprecipitated with a-Grb2 (lane 1, 2, 50 gg 
and 30 gg respectively). The immunocomplexes were then separated 
by SDS-PAGE and detected by Western blotting using a-Grb2 
antibody. The Grb2 protein is indicated by the arrow. (B) A549 cell 
lysates containing 50 gg and 30 gg of total proteins were 
immunoprecipitated with a-Met (lane 3, 4, 50 gg and 30 gg 
respectively). The immunocomplexes were then separated by SDS- 
PAGE and detected by Western blotting using a-Met antibody. The 
Met protein is indicated by the arrow. Indeed as expected A549 cells 
express detectable amount of Grb2 and Met ( 1 0  gg, lanes 1, 2 , 3 , and 4  
respectively). Strong background in this preliminary experiment is due to 
low dilution of secondary antibody.
3.3 Generation of GST-Grb2 and GST-P13-Kinase proteins
As outlined in the experimental procedures, GST-Grb2 proteins (Wt, SH2,C-SH3 
N,C-SH3 and SH2) and PI3-Kinase proteins (Wt, SH2 or SH3 domains) were 
prepared and analyzed for purity and yield on SDS-PAGE (Figure 3.4).
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52 kDa
Figure 3.4. Estimation o f  protein yield o f  P I 3 -Kinase and G rb 2  G S T  proteins. The y ie ld  and  
purity o f  S ep harose-cou pled  G S T  proteins (P I3-K in ase , G rb2) w as determ ined by reso lv in g  G S T  
proteins on 10% S D S -P A G E  together w ith serial d ilu tion s o f  com m ercia l B S A  (95%  purity). ( A )  P I3 -  
Kinase: G els stained w ith  C oom assie  B lue. T h e intensity o f  band stain ing w as com pared w ith  that o f  
the B S A  at con centrations ( I p g , 2 pg, 5 pg, and 10 pg, lanes 1, 2 , 3 , and 4  resp ective ly ). T h e PI3- 
K inase G S T -N -S H 2 , G S T -C -S H 2 , and G S T -S H 3  are in lanes 6 , 7, and 8. L anes 5 and 9  are con tro ls  
(pure G S T ). (B ) G rb 2  : G e ls  w ere stained w ith  C oom assie  B lu e and the intensity o f  band sta in ing  w as  
com pared w ith  that o f  the B S A . A n in tense band is v is ib le  at the 52  kD a s iz e  in all four lanes, 
indicating that Grb2 protein is  present in all sam p les (A p proxim ately  25 k D a o f  Grb2 and 25  k D a o f  
G S T ).
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3.4 Association assays using GST-Grb2 proteins and A431 Ivsates
In order to verify which domains of Grb2 mediate the association with Met, GST- 
Grb2 proteins were incubated with A431 lysates originating from HGF-treated or 
untreated ceils. Serum-starved A431 cells were treated with 100 ng/ml of HGF. 1.5 
mg of lysate protein was incubated with GST-Grb2 proteins for 2 hours at 4 ®C. The 
beads were collected washed three times with lysis buffer and bound species were 
released by heating in 4x laemli sample buffer (2% SDS, 62.5 mM Tris pH 6 .8 , 10% 
glycerol, 5% 2-mercaptoethanol) followed by SDS-PAGE and immunoblotting 
analysis. Wild type GST-Grb2 and N, C-SH3-lacking GST-Grb2 bound Met species 
from HGF-treated A431 lysates whereas SH2-lacking Grb2 was unable to bind Met. 
This result confirmed that lack of either SH3 domain from Grb2 proteins did not 
abolish their recruitment to the Met beta-subunit (Figure 3.5).
/  /  / / / /  /  / /
1 2 3 4 5 6 7 8 9  10
HGF untreated HGF treated
Figure 3.5. Binding of GST-Grb2 fusion proteins to Met. GST-Grb2 fusion 
proteins were incubated with A431 lysates from cells treated with (1-5) or 
without HGF (100 ng/ml) (6-10) for 10 min. Sepharose-bound proteins were 
resolved by SDS-PAGE and immunoblotted with a-Met. SH2-lacking Grb2 
does not bind Met.
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3.5 Confirmation that ceil clones expressed the transfected genes
Total cell lysates were prepared and immunoblotted with a-HA (Roche). This 
confirmed that cell clones expressed the transfected genes. The blots were stripped 
and re-probed with antibody to Grb2 and this further confirmed the size of the 
expressed genes.
/ /
?
97-
66-
55-
45-
43-
31-
21 -
17-
14-
HA-Wt-Grb2
Figure 3.6 Demonstration of HA-Grb2 proteins, stably expressed in A431 cells. 
Total cell lysates were prepared and immunoblotted with a-HA (Roche). Again 
the characteristic pattern of Wt-Grb2 and SH3 deletion mutants shows that the 
constructs are expressed in A431 cells. The band shown in lane 5 is due to the 
presence of a lower dilution marker (than lane 1) in lane 6 , which is not shown. 
The molecular weights of the marker standards are slightly altered by 
biotinylation.
3.6 Morphology and growth characteristics of the A431 Grb2-transformants
Three weeks after selection in Hygromycin B, A431 transformants were plated in 
75cm^ flasks with the aim to prepare enough cells for liquid nitrogen storage of the
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new cell lines. Clones were plated on day 1 at a density of 30% and fed with DMEM 
supplemented with 10% FCS and 400 pg/ml Hygromycin B (figure 3.7)
1. Wt-Grb2, and A-C-Grb2 cell clones, were significantly delayed in their 
proliferation and needed approximately 10 days to reach 90% confluence.
2. In addition, from day 2 to day 10, many rounded cells appeared in the flasks 
and were judged as cells with low viability undergoing apoptotic death. Wt- 
Grb2 transformants contained most of the rounded cells compared to the A-C- 
SH3-Grb2 clone.
3. A-N-Grb2 transformants showed the best rates of proliferation in 75cm^ flasks.
4. All clones appeared more elongated, than the A431 transfected with pEMP4.
A 4 3 1  T ransfected  w ith  p E M P 4 vector Wt-Grb2
A-C-Grb2 A-N-Grb2
Figure 3.7 A431 Transfectants. A 4 3 1  transfected w ith  p E M P 4 vector, compared with 
cell lines expressing Wt-Grb2 or Grb2 SH3 deletion mutants after 5 days in culture.
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3.7 Morphology and growth characteristics of the A549 Grb2-transformants
Wt-Grb2 and A-C-Grb2 could not proliferate and presumambly experieneed high 
apoptotic death. A test to verify apoptosis was planned to be the ApoAlert annexin V- 
FITC apoptosis kit (elontech: Cat No: K025-1), but although purchased, the test was 
never realized. Interestingly, one week after selection in G418 the A549 transformant 
A-N-Grb2 clone, was proliferating normally. No growth retardation or elevated 
apoptotic rate was observed. A stable cell line was obtained, which was cultured and 
expanded in T75 flasks with the aim to prepare enough cells for liquid nitrogen 
storage of the new eell line. Clones were plated in day 1 at a density of 30% and fed 
with DMEM supplemented with 10% FCS and 800 pg/ml Gentimicin. (figure 3.8)
1. Wt-Grb2 and A-C-Grb2 transfections showed a high apoptotie rate. Many rounded 
eells appeared in the dish and were judged as cells with low viability eventually 
experiencing apoptotic death.
2. A-N-Grb2 transformants took approximately 5-7 days to reaeh 90% eonfluence, 
but apoptotic rate was not as high as in the Wt-Grb2 and A-C-SH3 clones.
3. A-N-Grb2 were more elongated than the untransfected A549 cells.
m m
'A
Untransfected A549 Ceils A-N-Grb2 A549 Cells
Figure 3.8 A549 Transfected with A-N-Grb2. Untransfected A549 cells, 
compared to mutant stable cell line A549 A-N-Grb2, after 5 days in culture.
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C h a p t e r  I V
4. Results and Discussion o f Immunoprécipitations
The capacity of endogenous Grb2, as well as Grb2 derived from the Wt-Grb2, A-C- 
Grb2 and A-N-Grb2 transfected A431 cell lines to bind Met, Sos, She, and PI3-Kinase 
was determined by performing a series of immunoprécipitations. Also further 
immunoprécipitations were carried out to investigate the phosphorylation of proteins 
by the use of phosphotyrosine antibodies in untreated and HGF-treated samples. 
MAP-Kinase immunoprécipitations were also carried out, to investigate whether the 
Grb2 SH3 deletion mutants are sufficient to block that pathway. A431 transfected 
cells with the pEMP4 vector were used as control in all experiments, and where 
necessary lysates of HGF treated cells were used. These are outlined in separate 
sections below with a short discussion explaining each set of results.
4.1 Exogenously expressed Wt-Grb2 and SH3 deletion mutants do not form 
complex with Sos.
It is well established in the literature that Grb2 binds with great affinity to Sos (Buday 
and Downward 1994). Therefore I investigated whether exogenously expressed Wt- 
Grb2 and SH3 deletion mutants associate with Sos. Indeed as shown by the a-Grb2 
immunoprécipitations, Wt-Grb2 and both mutants bind to Sos in A431 cells (Figure 
4.1) but exogenously expressed Grb2 (a-HA) does not associate with Sos.
Sos
Blot a-Sos
' IP:Grb2
Figure 4.1. HA-Grb2 and SH3 mutants 
do not form complex with Sos. Cell 
lysates containing equal amount of total 
proteins were immunoprecipitated with 
a-Grb2 (lanes 1-5) and a-HA (lanes 6-10) 
The immunocomplexes were then 
- separated by SDS-PAGE and detected by
"v, M W e s t e r n  blotting using a-Sos antibody. 
The Sos protein is indicated by the arrow.
IP: HA '
1 2 3 4 5 6 7 8 9 10
NIH3T3 mouse Sos bands lower than 
human Sos, due to 2.4 kDa difference.
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To verify that indeed a-Ha Grb2 protein was expressed in cell lysates but did not form 
complex with Sos, the blot was stripped and re-probed with a-HA antibody. 
Immunoprécipitations of antibody to Grb2 (total Grb2), and a-HA (exogenously 
expressed Grb2) were carried out (figure 4.2) to distinguish between the endogenous 
and the exogenously expressed Grb2. The bands in a-HA are more intense than a- 
Grb2 due to high affinity of (a-HA) antibody.
WT
AN
AC
Blot a-HA
IP: Grb2 IP: HA
f  / / / / / / / /
T
1 2 3 4 5  6 7 8 9  10
Figure 4.2 Verification of HA- 
Grb2 expression in A431 
transfectants. Cell lysates 
containing equal amount of total 
proteins were immunoprecipitated 
with a-Grb2 (lanes 1-5) and a-HA 
(lanes 6-10). The 
immunocomplexes were then 
separated by SDS-PAGE and 
detected by Western blotting 
using a-HA antibody. The Grb2 
proteins are indicated by the 
arrows.
Next I investigated the pathway downstream of Grb2-Sos. In order to test whether 
both Grb2 SH3 mutants were able to associate with Sos, and subsequently able to 
activate Ras and the MAP-Kinase cascade, lysates from unstimulated and HGF 
stimulated A431 cells, were immunoprecipitated using antibody to phosphoMAP- 
Kinase and immunoblotted with the same antibody (Figure 4.3). This result showed 
that HGF-induced phosphorylation of MAP-Kinase is independent of Grb2 SH3 
deletion mutants. Also overexpression of Grb2, although increases the concentration 
of Grb2-Sos complex proximal to the cell membrane and the exchange of GDP to 
GTP does not activate Ras. This experiment was performed because in other systems 
overexpression of similar proteins has resulted to Ras activation (Rodrigues and Park 
1994).
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Figure 4.3. Grb2 SH3 mutants 
can transduce the HGF signal to 
the MAP-Kinase cascade. Non 
stimulated (lanes 1-4) and HGF 
stimulated (lanes 5-9) cell 
lysates containing equal amount 
of total proteins were 
immunoprecipitated with a- 
phospho-Erk 1/2. The 
immunocomplexes were then 
separated by SDS-PAGE and 
detected by Western blotting 
using an a-phospho-Erk 
antibody. Grb2 mutants can 
transduce the signal of HGF to 
the MAP-Kinase cascade as 
seen in lanes 8  and 9.
Overexpressed Grb2 indeed does not associate with Sos and therefore does not lead to 
MAP-Kinase phosphorylation as seen in figure 4.3 lane 2. However an additional 
approach to the issue, and a more accurate method would be the measurement of 
MAP-Kinase activity and Ras activity in all cell lysates.
The fact that exogenously expressed Grb2 (a-HA) does not bind with Sos may be due 
to a number of reasons including: a) saturation of Sos, b) phosphorylation of Grb2 or 
c) interaction with another protein.
Saturation of Sos
Due to absence of strong experimental data there is still a controversy about the 
amount of Grb2 relative to Sos in different cell types. It has also been proposed that in 
fibroblasts there is at least 3-10 times more Grb2 than Sos (Chardin et al 1995). One
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possibility therefore may be that due to the high amount of Grb2 in the A431 cells 
(Fig 3.2) when Grb2 is overexpressed not all Grb2 binds to Sos due to saturation of 
Sos. In another study with Grb2 mutants (A-N-SH3, A-C-SH3 and Wt) it was also 
suggested that Grb2 and its dominant negative forms may not be involved in Grb2- 
Sos interaction; but it may be that Grb2 is not available for interaction because of 
factors such expression level, subcellular localization, or association of Grb2 with 
another protein may be hindering Grb2-Sos complex formation (Tanaka et al 1995).
Overexpressed Grb2 not associated with Sos, would be free to bind with 
phosphotyrosine motifs through its SH2 domain, but would not lead to Ras activation, 
and therefore behave as a dominant negative in a Ras activation in Grb2/Sos 
transduction pathway. Although it has been observed that overexpressed Grb2 can 
inhibit signaling to Ras (Downward, 1994) no distinct pathways were assigned to 
Grb2 until recently. Different groups have observed that if only a fraction of Grb2 
pool is complexed to Sos, the remaining Grb2 would be free to bind to other proline 
rich proteins such as dynamin or synapsins; and such interaction could be involved in 
the internalization of growth factor receptors that rapidly follows activation, as a 
down regulation mechanism (Scaife et al 1994, Vidal et al 1998). Indeed SH3 
domains of Grb2 orchestrate the machinery necessary to translocate endocytic 
membranes carrying EGER from the periphery to the interior of the cell (Yamazaki et 
al 2 0 0 2 ).
Phosphorvlation of Grb2
It has been observed that tyrosine phosphorylated Grb2 in A431 cells reduced Sos 
SH3 dependent binding in vivo (Li et al 2001) and phosphorylated Grb2 acts as a 
novel mechanism of down regulation for tyrosine kinase signaling. Moreover in the 
same set of experiments EGF stimulation of A431 cells induced a change in mobility 
and tyrosine phosphorylation of Grb2, but phosphorylated Grb2 was virtually 
undetectable in a-Sos IP’s (Li et al 2001). Human Grb2 has a total of seven tyrosine 
residues: three in the N-terminal SH3 domain (Tyr 7, Tyr 37, and Tyr 52), two in the 
SH2 domain (Tyr 118 and Tyr 134), one between SH2 and the C-terminal SH3 
domain (Tyr 160) and one in the C-terminal SH3 domain (Tyr 209). Mass 
spectrometry of phosphorylated Grb2 and mutational analysis of Grb2 tyrosine
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phosphorylation has shown that phosphorylation of Tyr 209 in the C-terminal SH3 
domain of Grb2 reduces its binding to Sos (Li et al., 2001). Therefore it was decided 
to investigate phosphorylation levels of Grb2 (discussed in section 4.4).
Association with another protein
Being unable to detect a-HA-Grb2-Sos complex and suspecting apoptosis from 
observations of cell morphology in Grb2 transformants (Wt-Grb2 and A-C-Grb2) we 
wanted to investigate firstly whether overexpressed Grb2 sequesters PI3-Kinase. 
Association of the excess Grb2 with PI3-Kinase could explain both the growth 
retardation-apoptosis, and the non association of Sos with exogenously expressed 
Grb2. Therefore, we investigated, whether Grb2 forms a direct complex with PI3- 
Kinase as interactions of SH3 domains of Grb2 and proline-rich regions of PI3-Kinase 
have been reported (Wang 1995) (discussed in section 4.2).
4.2 Overexpressed Wt-Grb2 and SH3 deletion mutants do not form direct 
complexes with PI3-Kinase
One pathway interfering with cell survival and apoptosis activates PI3-Kinase which 
release phospholipids which activate PDKl and the anti-apoptotic serine/threonine 
kinase PKB/Akt. Evidence that increased PI3-Kinase activity was associated in cells 
expressing A-N-Grb2 (Rodrigues et al., 1997) probed investigations whether existence 
of direct association between the Grb2 SH3 domains and the proline-rich regions of 
the PI3-Kinase p85 subunit exist in our cell lines as was previously observed in other 
cell systems (Wang et al., 1995).
The immunoprécipitations of (total Grb2) (Figure 4.4) and a-HA-Grb2 (exogenously 
expressed Grb2) immunoblotted with antibody to PI3-Kinase did not support this 
hypothesis. Endogenous Grb2 was shown to associate with PI3-Kinase, whereas HA- 
Grb2 (exogenously expressed) immunoblotted with PI3-Kinase gave no signal, 
suggesting that imported Grb2 does not associate with PI3-Kinase as reasoned. The 
blot was stripped and immunoblotted with a-PI3-Kinase and a-Grb2 simultaneously. 
Grb2 was strongly visible in all a-HA immunoprécipitations but no association with 
PI3-Kinase was observed (fig 4.4B).
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Figure 4.4. (A) Endogenous Grb2 associates with PI3-Kinase. but HA-Grb2 
does not. Cell lysates containing equal amount of total proteins were 
immunoprecipitated with a-Grb2 (lanes 1-5) and a-HA (lanes 6-10 not shown, as 
no protein was detected). The immunocomplexes were then separated by SDS- 
PAGE and detected by Western blotting using an a-PI3-Kinase (p85) antibody. 
NIH3T3 mouse PI3-Kinase (p85) is 83,4 kDa and therefore runs faster on SDS- 
PAGE than human PI3-Kinase (p85) which is 83,6 kDa. (B) The blot was 
stripped and immunoblotted with antibody to PI3-Kinase and antibody to Grb2 
simultaneously (hence the compromised quality). Association of Grb2 was 
evident in the lower part of the blot in all a-Ha immunoprécipitations but no 
association with PI3-Kinase was detected. The fact that two bands are visible in 
a-Ha samples may suggest that a multi-complex of Grb2 (involving both 
endogenous and exogenously expressed Grb2) may be formed in these cells.
Exogenously expressed Grb2 does not interfere, at least directly with PI3-Kinase. 
Although associated PI3-Kinase activity was observed by Rodrigues (1997) in A-N- 
SH3 deletion mutant, this may well be through another indirect pathway involving 
Grb2, as no direct association between Grb2 and PI3-Kinase was observed in our 
cellular model. An alternative connection with Grb2 and PI3-Kinase could be allowed 
via an intermediate adaptor protein, potentially Gabl, or She.
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Indeed, multi-complexes involving both intermediate adaptors such as 
Grb2/Shc/Gabl/P13-Kinase have been reported to mediate signaling to PKB/Akt 
(Holgado-madruga et al., 1997, Gu et al., 2000, Ong et al., 2001). Also, other 
multicomplexes with Src/Cbl/P13-Kinase, which possibly may also involve She, have 
also been described recently (Kassenbrock et al., 2002). Although the role of Cbl is 
believed to be a ubiquitin ligase, mainly terminating signaling from tyrosine kinase 
receptors, recently it has been described that c-Cbl may act in multiple ways to enable 
it to regulate P13-Kinase and Akt as well as mediating receptor downregulation 
(Kassenbrock et al., 2002). Implications of She in the advancement of multicomplexes 
are evident, especially in the case of EGF receptor signaling, where Grb2 is recruited 
to the receptor via She. (See sections 1.10 and 1.11) Therefore our next investigation 
was to establish whether She co-immunoprecipitates with exogenously expressed 
Grb2.
4.3 Exogenously expressed Grb2 forms a Grb2-Shc complex which is not 
recruited to Met Receptor; a possible role in signal diversion.
Since multicomplexes of Grb2-Shc and P13-Kinase have been observed (Holgado- 
madruga et al., 1997, Gu et al., 2000) it seemed a logical approach to investigate 
whether sequestering of P13-Kinase was achieved via a Grb2-Shc complex, and 
whether the exogenously expressed Grb2 is diverted by She to other tyrosine kinase 
receptors such as EGF. Therefore, immunoprécipitations of total Grb2 (a-Grb2) and 
exogenously expressed Grb2 (a-HA), were immunoblotted with She antibody and 
revealed that indeed exogenously expressed Grb2 forms a complex with She (Figure
4.5).
She association with Grb2 was clearly evident in both immunoprécipitations with 
Grb2 and a-HA antibodies. It was detected that exogenously expressed Grb2 (a-HA- 
Grb2) not associated with Sos is associated with She. Wt-Grb2 and A-C-Grb2 had a 
strong detection signal (lanes 7 & 9) whereas A-N-Grb2 (lane 8 ) seemed to associate 
with She at a much lesser extend (Figure 4. 5). Binding affinity of Grb2 for She is the 
second highest after Sos, and the implications of Grb2 recruitment by She are 
complex. It has been observed that Grb2 recruitment by She in fibroblast growth
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factor receptor did not hinder association of Grb2 with Sos, while another pool of 
Grb2 was found in complex with a tyrosine phosphorylated 89 kDa component after 
FGF stimulation (Klint et al., 1995). Also, She has been observed to link Grb2 to 
other tyrosine kinase receptors that lack a Grb2 binding site (see section 1.11).
Blot: a-Shc
a-Grh2 «-HA
#  /  /  /
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Figure 4.5 HA-Grb2 associates with She. Cell lysates containing equal amount 
of total proteins were immunoprecipitated with a-Grb2 (lanes 1-5) and a-HA 
(lanes 6-10). The immunocomplexes were then separated by SDS-PAGE and 
detected by Western blotting using a-SHC antibody. She association with Grb2 
is clearly evident in both a-Grb2 and a-HA blots. The 3 band She pattern 6 6 , 52, 
46 kDa (not clearly seen due to high amounts of 46 and 52 kDa She, thus the two 
band pattern) indicates that exogenously expressed Grb2 (a-Ha) associates with 
She in a HGF-independent manner.
Therefore after She co-immunoprecipitated with Grb2, in Grb2 immunoprécipitations, 
immunoblotted with She, we performed immunoprécipitations of a-Shc and 
imunoblotted with a-Grb2, to show the opposite effect, and verify the result (Figure 
4.6.). Also in order to estimate the biological function of the complex, and see 
whether Grb2 is recruited to the Met receptor, or to other tyrosine kinases via She in
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unstimulated cells, a-Met immunoprécipitations were also immunoblotted with a- 
Grb2 in unstimulated cells (Figure 4.6). Experiments with EGF receptor although 
scheduled were not realized. In our set of results there was no association of Grb2 
SH3 deletion mutants with Met (Figure 4.6).
Grb2
Blot: a-Grb2
IP: She
2)*
IP: Met
/  /  /f
1 2 4 5 6  7 8
Figure 4.6. She associates with Grb2 in 
Grb2 SH3 mutants. Cell lysates 
containing equal amount of total 
proteins were immunoprecipitated with 
a-Shc (lanes 1-4) and a-Met (lanes 5- 
8 ). The immunocomplexes were then 
separated by SDS-PAGE and detected 
by Western blotting using a-Grb2 
antibody. She associates with Grb2 in 
Grb2 SH3 mutants (lanes 2-3), and 
Grb2 N-SH3 deletion mutant did not 
associate with Met (lane 7), whereas. 
Grb2 C-SH3 deletion mutant weakly 
associated with Met (lane 7).
In this set of results it is shown that She associates with Wt-Grb2 and both SH3 
mutants. As shown in figure 4.5, HA-Grb2, also co-immunoprecipitated with She in 
unstimulated cells independently of the SH3 deletion mutations because the binding 
site in Grb2 for She is conferred to the SH2 domain of Grb2 (See section 1.11). This 
association of Shc-Grb2 in unstimulated A431 cells is normal as preformed 
complexes of Grb2 with Sos and Grb2 with She also exist in quiescent cells (See 
section 1 .1 1 ).
Overall in unstimulated A431 cells there is no strong Grb2-Met interaction, however 
the weak detection of Wt-Grb2 association with Met in lane 5 can be explained by a 
recent finding of our group that 18% of cellular Grb2 is associated with the Met 
receptor in unstimulated A431 cells (Crostella et al., 2001).
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Normally the same should account for the SH3 deletion mutants since binding of 
Grb2 to Met is conferred to the SH2 domain of Grb2 as has been shown with GST- 
proteins (chapter 3 figure 3.6). However, A-C-SH3 Grb2 showed a weak association 
with Met, whereas A-N-SH3 Grb2 showed no association with Met. This result would 
be significant if an actin loading control was present. Under the circumstances no 
further conclusions can be drawn.
4.4 Direct association of Grb2 with She, results in phosphorvlation of both 
endogenous and exogenously expressed Grb2.
To investigate what are the implications of Shc-Grb2 complex in the signaling 
pathways, and whether Shc-Grb2 complex leads to Grb2 phosphorylation in 
unstimulated A431 cells, immunoprécipitations of a-phosphotyrosine antibody were 
immunoblotted with Grb2 (Figure 4.7). Interestingly, Grb2 double band pattern 
suggested that both exogenously expressed and endogenous Grb2 are phosphorylated 
on tyrosine. Since both endogenous and exogenously expressed Grb2 associate with 
She, (as shown in fig 4.5) we speculated that this associations may affect the tyrosine 
phosphorylation state of Grb2.
Blot: Grb2
HA-(||t>2
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Figure 4.7. Grb2 is 
phosphorvlated on tvrosine. 
Cell lysates containing equal 
amount of total proteins were 
immunoprecipitated with a- 
phosphotyrosine. The 
immunocomplexes were then 
separated by SDS-PAGE and 
detected by Western blotting 
using a-Grb2 antibody. The 
two bands in Wt-Grb2 and 
SH3 deletion mutants, suggest 
that both HA-Grb2 and 
endogenous Grb2 are 
phosphorylated.
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To show more clearly that exogenously expressed Grb2 becomes tyrosine 
phosphorylated, immunoprécipitations of a-HA, immunoblotted with a- 
phosphotyrosine antibody (4G10) were performed. Indeed Wt-Grb2 and both deletion 
mutants showed a weak sign of tyrosine phosphorylation. It was speculated therefore 
that since Grb2 becomes phosphorylated on tyrosine residues and co- 
immunoprecipitates with She, She may be phosphorylated as well. This was tested by 
immunoprécipitations using antibody to She and immunoblotting with a- 
phosphotyrosine. Again weak signs of tyrosine phosphorylation were observed in 
those lysates as well (data not shown due to compromised quality).
Tyrosine phosphorylation of Grb2 reduces its binding to Sos (Li et al 2001), which is 
in agreement with the results shown in section 4.1. Phosphorylation of overexpressed 
proteins in unstimulated cells is possible when such proteins form complexes that 
bind to a receptor and mimic ligand induced receptor dimerization and activation 
(Lemmon and Schlessinger 1994, Rodrigues and Park 1994). Speculation may 
therefore arise that by overexpressing Grb2 we increase substantially the Grb2-Shc 
preformed complex existing in unstimulated cells. Increased Grb2-Shc complex is 
recruited to receptor complexes, which are activated by membrane translocation 
(Schlessinger 2000) to become tyrosine phosphorylated on tyrosine residues and 
provide binding sites for multiple proteins. This non-specific tyrosine phosphorylation 
acts to diversify and localize signals downstream from receptors by virtue of the 
Grb2-Shc ability to assemble multiprotein complexes.
A possibility that overexpressed Grb2 not directly associated with any receptor can 
produce an inducible complex involving She protein has been characterized in NGF 
signaling (Suen et al., 1993). In other signaling pathways She has been found to be 
tyrosine phosphorylated in quiescent NIH3T3 fibroblasts although the critical initial 
signaling events involved and the regulatory factors that modulate these pathways still 
remain relatively undefined (Schlaepfer et al., 1998).
Tyrosine phosphorylation of such adaptor proteins usually activates the Ras and 
MAP-Kinase cascade (Takayama et al 1999 and Chen et al 1999). However since we 
investigated that the MAP-Kinase pathway is not activated by our induced complex 
(figure 4.3), then She is more likely to be involved in another signalling pathway.
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Whether another pathway, presumably apoptotic pathway is affected by our cellular 
model is to be discussed in the next chapter.
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C h a p t e r  V
5. DISCUSSION & FUTURE WORK:
5.1 Morphological characteristics of Grb2 cell transformants
Growth disadvantage (Apoptosis)
The analysis of the A431 transfected cell lines (figure 3.7) showed rounded cells with 
extended processes, which grew in a disorganized fashion and were less adherent than 
their normal counterparts. The Wt-Grb2 and A-C-Grb2 cells were of low viability and 
had a growth disadvantage compared to the A-N-Grb2. Apoptotic death, was highly 
suspected from microscopy examination, however because the apoptotic assay using 
the apoalert apoptosis kit (clontech) although scheduled was not performed, the term 
growth disadvantage is also used. In marked contrast, the A-N-Grb2 mutants showed 
the highest rate of proliferation and indeed had less “apoptotic” activity compared to 
the Wt-Grb2 and A-C-Grb2 transformants. The same observations but more lethal 
accounted for the A549 cell lines. The Wt-Grb2 and A-C-Grb2 were experiencing 
apoptosis at such a high rate that the achievement of a stable cell line transfected with 
these constructs became impossible. On the contrary, the A549 A-N-Grb2 cells grew 
again in an organized fashion with good proliferation rates and no rounded cells. Cells 
became more elongated and refractile at the edges (Figure 3.8). Generally Wt-Grb2 
showed a growth disadvantage compared to the A-N-Grb2 clone whereas the A-C- 
SH3 clone had a relatively weak effect. Interestingly, it has been reported that p85, 
the regulatory subunit of PI3-Kinase, interacts with Grb2 in vivo, in a growth factor- 
independent manner (Wang et al., 1995). The direct association between Grb2 and 
p85, when reconstituted in vitro, has indicated that the association is mediated by 
either of the SH3 domains of Grb2 and the proline-rich motifs of p85 and that only 
one SH3 domain is required for minimal binding (Wang et al., 1995). These 
observations, led to an initial hypothesis that an unknown apoptotic mechanism 
involving Grb2 and PI3-Kinase may exist. Therefore, after evaluating the data 
acquired from cell transfections, it was decided to proceed exploring whether the 
growth disadvantage induced by the Grb2 overexpression is accompanied by down­
regulation of PI3-Kinase activity. It is well established that the lipid products released
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by the PI3-Kinase activity via PDKl activate the serine/threonine Protein Kinase B 
(PKB/Akt) which is an established survival factor (Figure 5.1).
PI 3*Kinase
Tyrosine 
^  Phosphorylation
.I t *i
Survival
Factors
Figure 5.1 PI3-Kinase roles 
in apoptosis. The lipid 
oroducts released by the 
PI3-Kinase activity via 
PDKl activate the 
serine/threonine Protein 
Kinase B (PKB/Akt) which 
is an established survival 
factor (Figure adapted from TCS 
hiologicals official website).
Therefore the growth disadvantage conferred by the Grb2 overexpression could be 
due to PI3-Kinase dependent down-regulation of PKB/Akt. As a primary objective the 
identification of Grb2 downstream pathways and the roles of individual SH3 domains 
in PI3-Kinase direct or indirect down-regulation were researched and are discussed 
later on.
Branching tubulosenesis and elongation o f  cells.
Transfected A431 and A549 cells, apart from showing apoptotic activity, appeared 
more elongated and this is seen more in the A-N-SH3 transfectants (Figures 3.7 and
3.8 respectively). The strong co-localization of Grb2 to membrane ruffles (Gay et al., 
1999, Bar-Sagi et al., 1993) and the observation that selective inhibitors of the Grb2 
SH2 domain inhibited cell motility in HGF-treated A431 and MOCK cells has 
indicated a direct role of Grb2 in cell motility (Gay et al., 1999). Recently it has been 
shown that Grb2 SH2 domain antagonists blocked branching tubulogenesis in HGF-
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treated mammary epithelial cells (Atabey et al., 2001). A recent finding of our group 
also suggests that in addition to binding Sos and activating Ras, Grb2 SH3 domains 
target Grb2 to the cytoskeleton (Crostella et al., 2001). Branching tubulogenesis 
depends upon cell-cell interactions and cell substrate interactions mediated, at least in 
part, by E-cadherins, and integrins, and require a complex regulation of cell division, 
degradation and deposition of extracellular matrix (Gumbiner 1996 for review). Some 
of these responses may require activation of Ras through a Sos-Grb2 complex, 
although no precise mechanism has been proposed.
Branching tubulogenesis requires a functional Grb2 binding site at tyrosine 1356 in 
the Met receptor (Fournier et al., 1996) and that suggests that pathways downstream 
of Grb2 promote formation of branching tubules. However PI3-Kinase, PLC-y, SHIP- 
1, SHP-2, She, seem to share the same site and, although mutation of the Met receptor 
at Tyrl356 failed to produce branching tubules, that was restored with overexpression 
of Wt-Gabl, but not Grb2 (Lock et al., 2000). Moreover SHIP-1 overexpression 
drastically enhances the tubulogenesis potency of Met (Stefan et al., 2001) suggesting 
a complex signal transduction of activated Met.
Interestingly, Met mutated at binding motifs for Grb2, PI3-Kinase and Src tyrosine 
kinase, retained normal signaling through Gabl, but differentially recruited different 
effectors (Maina et al., 2001). These observations suggest that protein-protein 
interactions downstream of Grb2 can be complex and diverse, often implicating 
formation of multicomplexes. In our set of results we have shown that overexpressed 
Grb2 promotes Grb2-Shc complexes which presumably enhance branching 
tubulogenesis. Identifaction of proteins which interact with the Grb2-Shc complex 
should be the next step to provide more information about these cytoskeletal changes.
5.2 Shc-Grb2 complex in Ras Activation, and a dual role of She.
Grb2, as well as exogenously expressed Grb2, co-immunoprecipitated in all 
experiments with She. A431 cells bear abundant EGF receptor (1-2 x 10  ^ /cell) 
(Gamou et al., 1984, Haigler et al., 1979 and Krupp et al., 1982) which are known to 
associate with Grb2 via She (Buday, 1993). One possibility could be that 
overexpression of Grb2 in a high EGF-expressing cell line could result to a Shc-Grb2
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complex formation that would lead to non-specific tyrosine phosphorylation of EGF 
receptor. However EGFR work was not carried out, as such interaction would result 
to the activation of MAP-Kinase cascade, which is not supported by my results 
(Figure 4.3, section 4.4).
5.3 Grb2 and multicomplexes in survival pathways.
Grb2 and Gabl
It has been shown that formation of a Shc-Grb2-Gabl complex, mimics activated 
receptor tyrosine kinases and can induce Gabl tyrosine phosphorylation, which itself 
is associated with activation of MAP-K and PI3-Kinase pathways (Ong et al., 2001). 
A new role for She, in activation of the PI3-Kinase/Akt pathway has also been 
proposed in Interleukin receptor signaling (Gu et al., 2000) where association of She 
with the Grb2/Gab2 complex mediates PI3-Kinase activation. Binding of Grb2 to 
phospho-Shc recruits Gab2 to the IL-3 receptor complex, resulting in phosphorylation 
of Gab2 on YXXM motifs that bind PI3-Kinase SH2 domains (Gu et al., 2000). The 
subsequent production of PIP3 can generate survival signals through targets such as 
the Akt/PKB serine/threonine protein kinase. In the same set of experiments Gab2 
tyrosine phosphorylation was inhibited in cells co-transfected with either the Grb2 
SH2 mutant or SH3 double mutant compared to Wt-Grb2. These data suggest that 
both SH2 and SH3 domains of Grb2 are required for Gab2 tyrosine phosphorylation. 
These results strongly support a model in which the major route to Gab2 tyrosine 
phosphorylation is via formation of a Shc/Grb2/Gab2 complex. Also, the fact that 
NGF treatment of PC12 cells leads to increased Gabl associated PI3-Kinase activity 
and Grb2 showed NGF-induced association with Gabl (Holgado Madruga et al., 
1997) increases the potential of a similar model in our transformants implicating 
Shc/Grb2/Gab 1/PI3 -Kinase in the induction of a survival pathway through PKB/Akt. 
If that was the case in our experiments then an explanation to A-N-SH3 mutant 
resistance in apoptosis in both cell transformations A549 and A431 could be provided 
(figures 3.8 and 3.9.) In the case of A-N-SH3 mutant. She could bind to the SH2 
domain of Grb2, and Gabl or Gab2 would associate with Grb2 via the C-SH3 domain 
(Lewitzky et al., 2001, Lock et al., 2000, Schaeper et al., 2000) and subsequently 
induce the PI3-Kinase/Akt pathway and so cells would survive (Fig 5.1). However 
this hypothesis does not provide an explanation to the fact that Wt-Grb2 shows an
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even higher apoptotic effect than A-C-Grb2, and was therefore rejected. To answer 
how overexpression of Wt-Grb2 could induce an apoptotic pathway or rather inhibit a 
survival pathway, another protein should be examined.
Grb2 and Cbl
Since downstream of the Met receptor, the most highly tyrosine-phosphorylated 
proteins, correspond to the Cbl and Gabl docking proteins (Fournier et al., 2000, 
Nguen et al., 1997, Fixman et al., 1997), another possible candidate for linking Grb2 
to a cell survival pathway, which could also provide explanation for branching 
tubulogenesis is Cbl. One possible hypothesis is that Grb2 acts indirectly to recruit c- 
Cbl which contributes to the recruitment of PI3-Kinase (Fixman et al., 1997, Lock et 
al., 2000, Saucier et al., 2002). Evidence that a trimeric Grb2-Cbl-PI3-Kinase exists, 
is derived from experiments in activated Jurkat cells (Meisner et al., 1995). c-Cbl is 
known to down-regulate the Ras signal because its association with Grb2 leaves Sos 
“alone” in the cell cytosol. Therefore Sos-Grb2 and Cbl-Grb2 are present as distinct 
complexes and must activate distinct signalling pathways. Therefore since HA-Grb2 
was not detected in complex with Sos (Chapter 4.1) an association with Cbl is 
speculated. It is noteworthy that the sequence Y^^^EAM in Cbl forms a possible 
recognition site for p85 SH2 binding (Songyang et al 1994). Indeed in agreement 
with my results (figure 4.5) transient association of c-Cbl with She and PI3-Kinase 
after EGF stimulation suggests that Cbl functions as an adaptor molecule enhancing 
formation of multicomplexes (Kassenbrock et al., 2002). c-Cbl phosphorylation after 
stimulation of the Met receptor with HGF promotes coupling with PI3-Kinase, (Meng 
and Lowell 1998, Zell et al 1998). Mutated forms of c-Cbl showed that association 
and phosphorylation of Grb2, and p85, are independent of motility pathways and 
deletion of the proline-rich domain (Grb2 binding site) of c-Cbl had no effect in 
triggering epithelial motility (Fournier et al., 2000). Taken together trimeric Grb2- 
Cbl-PI3-Kinase is not activating a motility pathway. Genetic evidence that Cbl family 
members and their C.elegans ortholog Sli-1 are negative regulatory molecules, 
(Bachmaier et al., 2000, Naramura et al., 1998) along with recent biochemical studies 
showing that Cbl is a ubiquitin ligase that regulates RTK degradation (Joajeiro et al., 
1999), raises the possibility that association of p85 with c-Cbl functions to inactivate 
the PI3-Kinase/Akt pathway (Gu et al., 2000). Therefore it is very possible that c-Cbl
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association with Grb2 sequesters PI3-Kinase from the PI3-Kinase/Akt survival 
pathway (figure 5.2).
Wt-Grb2
N 3H3 J l  3H2 K C  SH3
0
# PIP3 • 
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AKT
X
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SH2 A . C 3 H 3
«•* * %
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Figure 5.2 Simplified proposed model for Grb2 sequestering of Cbl and 
effects of individual SH3 domains, on signal transduction pathwavs. The 
overexpressed Wt-Grb2 is able to sequester Cbl from a multicomplex involving 
Src and P/3-Kinase, which subsequently inhibits the survival pathway through 
PKB/Akt. A-N-SH3 mutant abolishes Cbl binding and does not sequester Cbl, 
therefore survival pathway remains unaffected. A-C-SH3 mutant can largely 
fulfil the functions o f Wt-Grb2 since it can sequester Cbl via the N-SH3 
domain.
Most importantly, because the binding capacity of Grb2 to Cbl is confined within the 
N-SH3 domain of Grb2, the overexpressed Wt-Grb2 protein can bind efficiently to 
Cbl via its N-SH3 domain and so the A-C-SH3, as shown by Waterman and co­
workers (Waterman et al 2002) but the A-N-SH3 transfectants should be unaffected
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since the survival pathway is not inhibited. Indeed this is in agreement with our cell 
morphology results (figures 3.7 and 3.8).
However the proposed model is very simplified and does not account for the 
involvement of other SH3 molecules such as Src. Recent work has established a role 
of c-Cbl in activation of survival pathways via Src as a Src/Cbl/PI3-Kinase complex, 
functions in Akt activation (Kassenbrock et al 2002). Src kinase Fyn induced 
phosphorylation of tyrosine 731 in Cbl which is the critical binding site for the p85 
subunit of PI3-Kinase. Furthermore the use of a Src kinase inhibitor (PPl) blocked 
EGF-induced activation of the anti-apoptotic protein kinase Akt. (Kassenbrock et al 
2002). The general implications on Src kinase activity in regulating Akt survival 
pathway may be more complicated. For example replacement of the multifunctional 
Met receptor binding site with specific binding motifs for PI3-Kinase, Grb2, and Src 
have indicated that signalling through other effectors other than PI3-Kinase, Grb2 and 
Src is required for Met-mediated hepatocyte survival (Maina et al 2001). In Met^^ 
(containing optimal motifs for p85) decreased activation of Akt, suggested that 
additional signals may be necessary to evoke full Akt activation (Maina et al 2001).
Grb2 can recruit other transducers through its SH3 domains necessary for Akt 
activation and survival, or even binding via the SH3 domain may promote negative 
regulation of the survival signal. c-Cbl which can bind SH3 domains is assigned the 
role of regulator of Src-family kinases (Anderson et al., 1997, Andoniou et al., 2000). 
However whether binding of c-Cbl to the SH3 domain of Src is leading to activation 
of the kinase or whether c-Cbl might use binding via the SH3 domain to promote 
negative regulation of the kinase is unclear. Although the signal transduction pathway, 
by which SH3 domains orchestrate the activation of anti-apoptotic pathway
(Kassenbrock et al., 2002) is not defined the cellular models used in this research
project can provide a powerful tool for studying apoptotic mechanisms involving 
individual Grb2 SH3 domains. Investigation of individual SH3 domains in an attempt 
to dissect signalling pathways, and identify new effectors and transducers of Grb2, is 
timely and appropriate. There is a great deal of future work that will help to
understand the amplification and diversion of cellular signals by protein
multicomplexes involving adapters such as Grb2, and this is discussed next.
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5.4 FUTURE WORK
The amount of work presented here surely is not adequate to answer the questions 
raised by the proposed hypothesis that individual Grb2 SH3 domains can divert cells 
to a particular phenotype such as motility or proliferation. It would therefore be 
worthwhile to investigate in future experiments, and address questions that would 
draw nearer to a definite conclusion concerning the hypothesis proposed. Immediate 
plans should include further characterization of the Grb2 transformants. This can be 
performed through the following experimental lines:
1. Evaluate the apoptotic activity of the Wt and dominant-negative clones by DAPI 
staining (counting fluorescent nuclei) and by Apoalert annexin V-FITC apoptosis 
kit (Cat No: K2025-1 Clontech).
2. Determine PI3-Kinase, MAP-Kinase and JNK activities in the Wt and SH3 
deletion mutants cell lines in response to HGF and after treating the cell clones 
with or without various inhibitors (wortmannin, LY294002 etc.)
3. Estimate by immunoprécipitations whether HA-Grb2 originating from Wt and 
Grb2 SH3 deletion mutants A431 cell lines binds the Gab2, Gabl and Cbl 
proteins.
4. Perform GST-association assays using the Grb2 and PI3-Kinase GST proteins to 
determine binding affinity of SH3 deletion mutants and pull down assays to 
determine binding capacities of the SH3 deletion mutants. Also determine the 
capacity of SH3 mutants to bind Gab2, Gabl and Cbl proteins.
5. Perform a number of biological assays to evaluate the adhesion, scattering, 
motility and invasive properties of Wt and SH3 deletion mutants cell clones.
The growth disadvantage conferred by the Wt-Grb2, and A-C-SH3 deletion Grb2 
mutant to the A431 cells is an interesting finding which may trigger further 
investigation of the role of Grb2 SH3 domains in HGF-induced proliferation and or 
motility. An issue which still remains undefined and should be addressed in future 
experiments will be the potential involvement of the Grb2 SH3-domains in modifying
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PI3-Kinase activity. An alternative approach in search for the identification of 
effectors which potentially lead the integration of the initiatory signal into a specific 
phenotype would be to import peptides bearing the active sites for these effectors, into 
cells, and via competition with the sites in endogenous counterparts, could lead to the 
“switching o ff’ or enhancement of a particular phenotypic response (Kardinal et al., 
2001).
Altrematively the use of the relatively new technique of RNA interference (RNAi) 
could be employed. Since Grb2 gene sequence is known, post-transcriptional 
inhibition of Grb2 gene expression can be achieved by designing a dsRNA and 
delivered into the cells. This technique would prove particularly useful in the A549 
experiments where transfection of cells with Wt-Grb2 and A-C-Grb2 was lethal. An 
additional approach could include the use of point mutated SH3 domains where a 
replacement of a single base pair with another pair would selectively inhibit binding 
to downstream effectors as described previously in Grb2 SH3 domains (Tan et al., 
1999, Jiang et al., 2003) and in Crk SH2 domains (Senechal et al., 1998). Studying 
multicomplexes formation and understanding signal transduction by adaptor proteins 
such as Grb2 requires indeed a great deal of work. As an epilogue to this thesis I 
would like to include a comment on future work from an expert in the field of adaptor 
proteins:
“For a better understanding of how such large signalling complexes are assembled, 
coordinated and used to generate specific signals, it will be necessary to perform in 
depth biochemical analyses and reconstitution experiments, similar to studies 
previously done with equally complex systems, for example the basal transcription 
machinery. To complicate things, it may be necessary to include membrane and 
cytoskeletal components or even focal adhesion-like structures into such assays in 
order to allow the proper assembly of the signalling complexes. These biochemical 
reconstitution experiments have to be accompanied by the simultaneous observation 
of multiple tagged proteins in living cells in order to validate in vitro findings in 
vivo.’^  (Feller 2001)
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Appendix I.
In many sections of the thesis and especially in the introduction (sections 1.3 and 1.8) 
many mutations or substitutions of various amino acids are discussed, therefore I hope 
this table will provide a better understanding of the significance of these changes.
CAS
Registry
Number
Mol
Wt
Name
Abbreviation Structure formula
CH3-CH(NH2)-COOH
Alanine 89.09 6.00 56-41-7ala a OH
NH
HN=C(NH2)-NH-(CH2)3-CH(NH2)-
COOH
NH OArginine
argr 11.15:74-79-3174.20
OH
NH
H2N-CO-CH2-CH(NH2)-COOH
Asparagine 
asn n 132.12 5.41 5794-13-8 OH
NH
HOOC-CH2-CH(NH2)-COOH
Aspartic acid 
asp d HO133.10 12.77 56-84-8 OH
NH
HS-CH2-CH(NH2)-COOH
Cvsteine 
cys c 121.15 5.02 52-90-4 HS OH
NH
H2N-CO-(CH2)2-CH(NH2)-COOH
Glutamine 146.15 5.65 56-85-9glnq OHKN
NH
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HOOC-(CH2)2-CH(NH2)-COOH
Glutamic acid 147.13 3.22 56-86-0glue HO OH
NH
NH2-CH2-COOH
Glycine
giy g
75.07 5.97 56-40-6
OH
N=C-NH-C=C-CH2-CH(NH2)-COOH
Histidine 155.16 7.47 71-00-1his h
OH
NH
CH3-CH2-CH(CH3)-CH(NH2)-COOH
Isoleucine 131.17 5.94 73-32-5ile i OH
NH
(CH3)2-CH-CH2-CH(NH2)-COOH
Leucine 131.17 5.98 61-90-5leu 1 OH
NH
H2N-(CH2)4-CH(NH2)-COOH
Lysine 
lys k
39665-12146.19 9,59
OH
NH
CH3-S-(CH2)2-CH(NH2)-COOH
Methionine 149.21 5.74 63-68-3met m OH
NH
Ph-CH2-CH(NH2)-COOH
Phenylalanine 
phe f 165.19 5.48 63-91-2 OH
NH
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NH-(CH2)3-CH-COOH
Proline 147-85-36.30115.13prop
OH
NH
HO-CH2-CH(NH2)-COOH
Serine 56-45-15.68105.09 HO OHser s
NH
CH3-CH(OH)-CH(NH2)-COOH
Threonine 72-19-5119.12 5.64thr t OH
NH
Ph-NH-CH-C-CH2-CH(NH2)-COOH
Tryptophan 
trp w 204.23 5.89 73-22-3 OH
NH
HO-p-Ph-CH2-CH(NH2)-COOH
Tyrosine
tyry 181.19 5.66 60-18-4 OH
NH
HO
CH3-CH(CH2)-CH(NH2)-COOH
Valine 117.15 5.96 72-18-4yal V OH
NH
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Appendix II.
Restriction enzymes buffer guide & Restriction Enzymes details 
Buffer Guide
Buffer typ e Cone. Com position
Low salt buffer lOx L 100 mM Trls-HCI, pH 7.5
100 mM MgClz
10 mM DIthiothreitol
Medium salt buffer lOx M 100 mM Tris-HCI, pH 7.5
100 mM MgCh
10 mM DIthiothreitol
500 mM NaCI
High salt buffer lOx H 500 mM Tris-HCI, pH 7.5
100 mM MgCh
10 mM DIthiothreitol
1000 mM NaCI
Potassium buffer lOx K 200 mM Tris-HCI, pH 8.5
(KCI) 100 mM MgCh
10 mM DIthiothreitol
1000 mM KCI
Eco52 I basal buffer lOx Basal 100 mM Tris-HCI, pH 8.9
30 mM MgCh
1000 mM NaCI
0.1%  BSA
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Restriction Enzymes details
B g l l
GCCNNNNiNGGC
D escription: Isolated from Bacillus globigii. 
Heat inactivatabie: Yes, 65 °C for 15 minutes.
Unit d efin ition Ligatlon-recutting
DNA Buffer tem p ligated Recut
X Basal 37 °C > 90% > 90%
Hind III
AiAGCTT
D escription: Isolated from Haemophilus influenzae Rd. 
Heat inactivatab ie: Yes, 70 °C for 15 minutes.
Unit defin ition Ligation-recutting
DNA Buffer tem p ligated j recut
X M 37 °C 100% I 100%
BamH I
GiGATCC
Description: Isolated from Bacillus amyloliquefaciens H. 
Heat inactivatabie: Yes, 60 °C for 15 minutes.
Unit defin ition L igation-recutting
DNA Buffer tem p ligated recut
X K 30 ®C > 95% 100%
S a / l
GiTCGAC
Description: Isolated from Streptomyces albus G. 
Heat inactivatabie: Yes, 60 °C for 15 minutes.
Unit defin ition L igation-recutting
DNA j Buffer tem p ligated recut
X I H 37 °C > 95% 100%
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B u f f e  rs
Ciyopreservation buffer
10% DMSO, 20% DMEM and 70 % Fetal Calf Serum.
Coomassie Blue
Methanol 100 ml, acetic acid 100 ml coomassie blue Ig purchased from Sigma Cat No: 
BO 149, and deionized water to 1000 ml.
SOC medium
0.5% yeast extract, 2.0% tiyptone, 10 mM NaCI, 2.5 mM KQ, 10 mM Tv^Clz,
10 mM A/%SO^ , 20 mM sucrose.
STE buffer
2ml of 5 M NaCI, 1ml of IM Tris pH 8.0,0.2ml of 0.5 EDTA pH 8.0, 
made up to 100 ml with ddHjO
TE
lOmM of Tris-HCI pH  7.4, ImM EDTA pH 8.0. 
buffer A
lOg sucrose, 1.25 ml IM Tris pH  7.4,1.0 ml of 0.5 EDTA, 
made up to 50ml with ddHzO
General lysis buffer
lOmM Tris-HCI, pH  7.4,1% (v/v) Triton X-100, 0.5% Nonidet P40,150 mM NaQ, ImM 
PMSF.
Lysis buffer, phosphorylation studies.
lOmM Tris-HCI, pH  7.4, 1% Triton X-100 (w/v), 0.5% Nonidet P40, 150 mM NaCI, 
ImM PMSF and sodium orthovanadate at 0.2 mM (finaÇ
Immunoprécipitation buffer
10 mM Tris-HCI, pH  7.4, 1% Triton X-100 (w/v), ImM EDTA, 0.2Mm sodium ortho­
vanadate, 0.5% Nonidet P40,150 mM NaCI, ImM PMSF
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4x Laemmli buffer
2% SDS, 62.5 mM Tris H Q  pH 6.8,10% glycerol, 5% 2-mercaptoethanol.
Kinase assay buffer
25 mM HEPES, 2mM MgQj, 0.2 mM sodium orthovanadate in the presence of lOpG 
[y ATP], sp.activity >7000 Q/mmol.
SDS-PAGE
Separating gel
2.75 ml of 30% acrydamide/ 0.8% bisacrydamide, 2.05 ml of 4x Tris-HQ/SDS pH 8.8, 
3.45 ml of dH20, 27.5 pi of 10% ammonium persulphate, and 15 pi of TEMED.
Stacking gel
1 ml of 30% acrylamide/0.8% bisacrylamide, 1.9 ml of stacking gel buffer, 4.4 ml of dHjO, 
40 pi of 10% ammonium persulphate, and 20 pi of TEMED.
Wash buffer
IxPBS (Phosphate buffered saline) containing 0.1% (w/v) Tween-20 and 5 % BSA,
Buffer A (or Acrylamide stock):
Final MW Per 100ml
30% (w /v) acrylamide 71.08 29.2g
0.8% (w /v) bis- acrylamide 154.17 0.8g
*1* Store protected from light in brown glass bottle (or wrap with foi^.
♦t* Dissolve in 50-70ml MilliQ water by stirring until dissolved.
♦t* Can de-ionize with mixed bed resin and filter throt^h a 0.22 filter. (Sigma M-8032) 
Store at 4 °C and make fresh each month.
Buffer B (or 4xrunning gel buffer pH  8.8):
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Final MW Per 100ml
1.5M Tris-HCLpH 8.8 121.1 18.16g
0.4% SDS 288.38 0.4g
*1* Very important to check pH  and adjust with concentrated HCl.. 
K* For SDS add 0.8ml in 100ml or 4ml in 500ml.
♦♦♦ Store at 4 °C and make fresh each month.
Buffer C (or 4xrunning gel buffer p H  6.8):
Final MW Per 100ml
0.5 M Tris-HCI, pH  6.8 121.1 6.05g
0.4% SDS 288.38 0.4g
❖ Store at 4 °C and make fresh each month.
*1* For SDS add 0.8ml in 100ml or 4ml in 500ml.
Am m onium  Persuphate 10%: 1 g in 10 ml distilled water. Aliquot in 1 ml microtubules 
freeze at -  20 °Q or make fresh twice a month. Not to be thawed more than 5 times.
TEM ED : is the catalyst for acrylamide polymerisation reaction, add always just before 
pouring the gel.
SDS-PAGE-reservoir buffer lOx
Final lOx MW IL
25 mM  Tris 0.25M 121.1 30.3g
192mM Glycine 1.92M 75.07 144.1g
0.1% SDS (w /v) 1.0% lOg
❖ For SDS add 1ml of 10%. 
Anode 1 (121.14X0.3=36.342)
Final MW Per 500ml P eril
0.3M Tris-HCI 121.1 18.171g 36.342g
20% M ethanol 100ml 200ml
Anode 2 (25/1000=0.0025X1211.14=3.0285)
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Final MW Pet 500ml Pet 11
25mM Tris-HCI 121.1 1.514g 3.0285g
20% M ethanol 100ml 200ml
Cathode
Final MW Pet 500ml Pet 11
25mM Tris-HCI 121.1 1.514g 3.0285g
40mM Am inocaptoic acid 131.18 2.624 5.248
20% M ethanol 100ml 200ml
Striping buffet =  500ml 62.5Mm TrisHQ (3.78g) 2% SDS (20 ml from 10%) lOOmM 
Beta-Mercaptoethanol (3.5ml) add water to 0.51
❖ Mix with magnetic stirrer and use Beta-Mercaptoethanol in a fume cupboard. Strip 
for 30 min at 50°C.
Lysis Buffet 500ml
Chemical MW Final fot 500ml
lOmM Tris-HCI, pH7.4, 121.1 0.6055g
l% v/ V Triton X-100, 5 ml
0.5% Nonidet P40, 2.5 ml
150 mMNaCl, 58.5 4.386g
0.2 mM sodium orthovanadate Na^VO.^ 183.9 0.018g
ImM PMSF
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Appendix III.
G e n e ra l G r b 2  in fo r m a tio n
A lth o u g h  th e  a im  o f  th e  p ro jec t is  m erely  to  in v estig a te  th e  sign ifican ce  o f  th e  in d iv idu al 
S H 3  d o m a in  o f  G r b 2  p ro te in , sp ec ifica lly  in  M et recep tor  sign alin g, m an y  q u e stio n s  arisen  
fro m  th is w o r k  m a y  req u ire co n sid era tio n  o f  th e G rb 2  p ro te in  in  a w id er  co n tex t. 
T h e r e fo r e  I d e c id e d  t o  in c lu d e  s o m e  tab les an d  d iagram s that w o u ld  h e lp  ap p recia te G rb 2  
w ith o u t  b u r d e n in g  th e  te x t  w ith  gen era l in form ation .
1000
100
1 0 -  
1 -  
0
mil
I I I I I
l i l l l
BMR Bone marrow 
I  Immune System SPL ^ l e e n  
IMS Tnymus
I  Neivous System ^  cord
Muscle HeartSkeletal muscle
. LVR Lwer
I  Secretoiy Glands PNC P ancreas 
PST Prostate
! KDN Kidney LNG Lung■  Other□  Min-max range for duplicates
BMR SPL IM S BRN SPC  HRT M SI LVR PNC PST KDN LNG 
Figure 1 A. GRB2 expression in normal human tissues based on 
proprietary W.I.S DNA array (GeneNoTE) results
w  clones
BMR SPL TMS BRN SPC HRT MSL LVR PNC PST KDN LNG
Figure IB. GRB2 expression in normal human tissues based on 
quantifying ESTs from various tissues in Unigene clusters
Qoms Total
TltMt per gene donee
BMR BBMMrroti 1 26,000
SPL SpteN 1 13,409
TMS Thjpn 1 3,451
BRN 35 274,393
SPC S^Mfd 0 506
Hetrt 2 35,070
SkdeWMtde 2 23,264
LVR Lifer 4 55,430
PNC PsMfen 3 58,927
PST PretUe 1 81,135
KDN KMee, 1 121,315
LNG Lnj 12 167,397
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Homologues:
gene locus description %simiiarity to human
mouse
(MGD) Grb2 11 (75.00 cM^
growth factor receptor bound 
protein 2 —
fly
(euGenes) drk 2 50B7
RAS protein signal transduction
SH3/SH2
adaptor protein
65%
C. elegans 
(euGenes) sem-5
X
7995288..7996908 C. elegans sem-5 58%
C. elegans
(Stony
Brook)
C14F5.5 —
Caenorhabditis elegans cosmid 
C14F5,
complete sequence
70,18% ;
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